Abnormal Movements

Abnormal involuntary movements which primarily affect the extremities, trunk, or jaw that occur as a manifestation of an underlying disease process. Conditions which feature recurrent or persistent episodes of dyskinesia as a primary manifestation of disease may be referred to as dyskinesia syndromes (see MOVEMENT DISORDERS). Dyskinesias are also a relatively common manifestation of BASAL GANGLIA DISEASES.

Synonym
Hemiballismus
Asterixis
Tardive Oral Dyskinesia
Orofacial Dyskinesia
Involuntary Movements
Abnormal Movements
Lingual-Facial-Buccal Dyskinesia
Linguofacial Dyskinesia
Dyskinesias
Hemiballism
Oral Dyskinesia
Ballismus
Oral-Facial Dyskinesia

Excerpt	Reference
"Peak-dose dyskinesias are the most common side effects of levodopa therapy for PD."	( Aguglia, U; Andreoli, V; Annesi, G; Branca, D; Cittadella, R; Civitelli, D; Gambardella, A; Montesanti, R; Nicoletti, G; Oliveri, RL; Pasqua, AA; Quattrone, A; Spadafora, P; Zappia, M, 1999)
"Paroxysmal dyskinesias are genetically and clinically heterogeneous."	( Vidailhet, M, 2000)
"Involuntary movements are not a known feature of vitamin B12 (vB12) deficiency in adults, though they are a characteristic feature of vB12 deficiency in infants."	( Barkut, IK; Celik, M; Forta, H; Oncel, C, 2003)
"Hemiballismus is characterized by the abrupt onset of violent proximal flinging movements, affecting the limbs, neck and trunk on one side of the body."	( Buraczyńska, K; Pilarczyk, M; Sagan, M; Stelmasiak, Z; Tynecka, M, 2003)
"Hemiballismus is a rare movement disorder characterized by involuntary, large amplitude movements of the limbs of 1 side of the body."	( Bailey, KM; Cai, C; Carrillo, A; Fitzsimmons, C; Mukand, JA; Wennemer, HK, 2005)
"Dyskinesias are a common consequence of dopaminergic therapy in patients with Parkinson's disease."	( Chu, Y; Collier, TJ; Kordower, JH; Maries, E; Olaru, E; Shannon, K; Sortwell, CE; Steece-Collier, K, 2006)
"However, such dyskinesias are probably not a novel phenomenon."	( Cenci, MA; Hagell, P, 2005)
"Dyskinesias are a transient but severe complication of subthalamotomy in some patients."	( Antico, J; Merello, M; Obeso, JA; Perez-Lloret, S, 2006)
"Dyskinesias are affected by placebo treatment."	( Damier, P; Goetz, CG; Hicking, C; Laska, E; Müller, T; Nutt, J; Rascol, O; Russ, H; Warren Olanow, C, 2008)
"Off-medication dyskinesias are common following transplantation and may represent a prolonged form of diphasic dyskinesias."	( Freeman, T; Godbold, J; Goetz, CG; Gracies, JM; Kordower, JH; Obeso, JA; Olanow, CW; Stoessl, AJ, 2009)
"Dyskinesias are common in Parkinson disease (PD)."	( de la Fuente-Fernandez, R; Mak, E; Ruth, TJ; Schulzer, M; Sossi, V; Stoessl, AJ; Troiano, AR, 2009)
"Involuntary movements are not generally regarded to be TIA or RIND."	( Ishizaka, S; Kawahara, I; Matsuo, Y; Nakamoto, M; Tokunaga, Y; Yagi, N, 2008)
"The paroxysmal dyskinesias are a heterogeneous group of movement disorders."	( Chillag, KL; Deroos, ST, 2009)
"Graft-induced dyskinesias are serious adverse effects and a major roadblock for the further development of cell therapies, and functional imaging can help investigate the mechanisms underlying their cause."	( Piccini, P; Politis, M, 2010)
"Dyskinesias are some of the major motor complications that impair quality of life for patients with Parkinson's disease."	( Hisanaga, K; Kawamura, T; Kuno, S; Nomoto, M; Oeda, T; Sawada, H; Yamamoto, K; Yamamoto, M, 2010)
"Graft-induced dyskinesias are a serious complication after neural transplantation in Parkinson's disease."	( Bjorklund, A; Brooks, DJ; Lindvall, O; Oertel, WH; Piccini, P; Pogarell, O; Politis, M; Quinn, NP; Wu, K, 2011)
"Diphasic dyskinesias are a subtype of levodopa-induced dyskinesias that appear typically at the onset and end of levodopa antiparkinsonian action."	( Alegre, M; Alonso-Frech, F; Artieda, J; Guridi, J; López-Azcárate, J; Obeso, JA; Rodríguez-Oroz, MC; Valencia, M, 2012)
"Dyskinesias are involuntary muscle movements that occur spontaneously in Huntington's disease (HD) and after long-term treatments for Parkinson's disease (levodopa-induced dyskinesia; LID) or for schizophrenia (tardive dyskinesia, TD)."	( Al Hadithy, AF; Alifirova, VM; Brouwers, JR; Fedorenko, OY; Freidin, MB; Govorin, NV; Ivanova, SA; Loonen, AJ; Pechlivanoglou, P; Rudikov, EV; Semke, AV; Sorokina, VA; Wilffert, B; Zhukova, IA, 2012)
"Reserpine-induced orofacial dyskinesia is a model that shares some mechanists' aspects with tardive dyskinesia whose pathophysiology has been related to oxidative stress."	( Kawale, LA; Khatri, ML; Nade, VS; Patil, NR; Shendye, NV, 2013)
"Hemiballism is a rare movement disorder characterised by high-amplitude movements of the limbs on one side of the body."	( Hattori, N; Noda, K; Okuma, Y, 2015)
"Dyskinesias are a disabling motor complication that arises with prolonged l-dopa treatment."	( Bordia, T; Perez, XA; Quik, M; Zhang, D, 2017)
"Hemichorea-hemiballism is a syndrome secondary to different etiologies."	( Aldinio, V; Bullrich, MB; Da Prat, G; Gatto, EM; Parisi, V; Persi, G; Rojas, G; Sanchez, P, 2017)
"Dyskinesias are abnormal involuntary movements that patients with mid-stage and advanced Parkinson's disease (PD) may suffer from."	( Burack, MA; Ghoraani, B; Hssayeni, MD; Jimenez-Shahed, J, 2020)
"Involuntary movements are common, but poorly recognized feature of motor neuron disease that may add to functional impairment."	( Dolenc Grošelj, L; Kojović, M; Koritnik, B; Leonardis, L; Saifee, TA; Vogelnik, K; Zidar, J, 2022)
"Moreover, dyskinesias are considered signs of excessive dopaminergic neurotransmission in Parkinson's disease, but they are typically more severe on the body side that is more strongly affected by dopamine depletion."	( Falkenburger, B; Kalliakoudas, T; Reichmann, H, 2022)
"Hemichorea-hemiballismus is a rare hyperkinetic movement disorder."	( Batot, C; Chea, M; Degos, B; Mazoyer, J; Mongin, M; Pop, G; Zeidan, S, 2022)

Excerpt	Reference
"These dyskinesias have shown a different temporal development postoperatively compared to the antiparkinsonian graft effects, and no significant relationship with the magnitude of graft-derived dopaminergic reinnervation or symptomatic relief."	( Cenci, MA; Hagell, P, 2005)
"Dyskinesias have a negative impact on quality of life and are an important cause of disability."	( Albanese, A; Del Sorbo, F, 2008)
"These dyskinesias have been severe in a number of patients and represent one of the main obstacles for further development of the cell therapy in PD."	( Carlsson, T; Döbrössy, M; García, J; Nikkhah, G; Winkler, C, 2012)
"Asterixis has been reported as a side effect of toxic and metabolic abnormalities."	( Wahba, M; Waln, O, 2013)

Excerpt	Reference
"Dyskinesias are affected by placebo treatment."	( Damier, P; Goetz, CG; Hicking, C; Laska, E; Müller, T; Nutt, J; Rascol, O; Russ, H; Warren Olanow, C, 2008)

Excerpt	Reference
"Peak-dose dyskinesias are the most common side effects of levodopa therapy for PD."	( Aguglia, U; Andreoli, V; Annesi, G; Branca, D; Cittadella, R; Civitelli, D; Gambardella, A; Montesanti, R; Nicoletti, G; Oliveri, RL; Pasqua, AA; Quattrone, A; Spadafora, P; Zappia, M, 1999)
"Abnormal involuntary movements known as dyskinesias are amongst the most disabling side-effects of levodopa therapy."	( Clarke, CE; Crosby, NJ; Deane, KH, 2003)
"Finally, the undesired motor dyskinesias that commonly accompany long-term L: -DOPA therapy, can be viewed as an outcome of L: -DOPA's sensitizing DA receptors (D(1)-D(5)), an effect easily replicated by repeated DA agonist treatments (especially agonist of the D(2) class) in animals, even if the brain is not DA-denervated."	( Brus, R; Kostrzewa, JP; Kostrzewa, RA; Kostrzewa, RM; Nowak, P, 2005)
"To further understand its role in dyskinesias, we mapped opioid receptor-stimulated G-protein activation using [35S]guanylyl-5'-O-(gamma-thio)-triphosphate ([35S]GTPgammaS) autoradiography in the basal ganglia of normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned squirrel monkeys administered water or L-DOPA."	( Chen, L; Di Monte, DA; Langston, JW; Quik, M; Togasaki, DM, 2005)
"In this group, the severity of dyskinesias during the third and fourth weeks of treatment was significantly higher than the group treated with l-Dopa alone."	( Bédard, PJ; Di Paolo, T; Grégoire, L; Hadj Tahar, A; Rouillard, C; Samadi, P, 2005)
"Abnormal involuntary movements occurred only in the L-dopa-primed 6-OHDA-lesioned rats that showed after acute l-dopa administration a decrease in firing rate, the highest local field potential power in the theta/alpha band, a consequent oscillatory activity in the same frequency band at the single neuron level and an excessive increase in striatal DA release associated with the lowest level of DA metabolism."	( Bezard, E; Bioulac, B; Boraud, T; Gross, CE; Harnack, D; Klitgaard, H; Kupsch, A; Meissner, W; Morgenstern, R; Ravenscroft, P; Reese, R, 2006)
"In 1 patient with severe dyskinesias and fluctuations, pk/pd of l-dopa were evaluated before and after coadministration of tolcapone at 100 mg 2 times daily for 1 month."	( Adamiak, U; Bialecka, M; Gawronska-Szklarz, B; Kaldonska, M; Klodowska-Duda, G; Safranow, K; Wyska, E, 2010)
"Motor fluctuations and dyskinesias are common motor complications that manifest within the first few years from the initiation of therapy in patients with Parkinson disease."	( Espay, AJ, 2010)
"These dyskinesias have been severe in a number of patients and represent one of the main obstacles for further development of the cell therapy in PD."	( Carlsson, T; Döbrössy, M; García, J; Nikkhah, G; Winkler, C, 2012)
"The development of dyskinesias following chronic L-DOPA replacement therapy remains a major problem in the long-term treatment of Parkinson's disease."	( Aron Badin, R; Auguet, M; Bertrand, A; Boulet, S; Brouillet, E; Chabrier, PE; Dollé, F; Gaillard, MC; Guillermier, M; Hantraye, P; Jan, C; Malgorn, C; Savasta, M; Spinnewyn, B; Van Camp, N, 2013)
"They also displayed reduced abnormal involuntary movements after apomorphine and quinpirole treatment in the mouse dyskinesia model of Parkinson's disease."	( Ferger, B; Hengerer, B; Oeckl, P, 2014)
"Despite overlap in some patients, dyskinesias will be treated separately from dystonia and chorea; benefit was not established beyond individual patients for these conditions."	( Koppel, BS, 2015)
"Motor fluctuations reversed in 37% and dyskinesias in 49% of patients on oral treatment and remained generally mild in those with persistent complications."	( Alves, G; Bjornestad, A; Forsaa, EB; Larsen, JP; Pedersen, KF; Tysnes, OB, 2016)
"Levodopa (L-DOPA)-induced dyskinesias (LIDs) represent the major side effect in Parkinson's disease (PD) therapy."	( Cirnaru, MD; Di Luca, M; Gardoni, F; Mellone, M; Perez-Carrion, M; Piccoli, G; Stanic, J; Zianni, E, 2016)
"We wish to emphasize that acute orofacial dyskinesia and extremity dyskinesia can be observed during methylphenidate therapy and that biperiden can be successfully used in the treatment of this unpleasant condition."	( Arslan, E; Arslan, EA; Göksu, Ö; Kilinç, A, 2018)
"RESULTS The total frequency of involuntary movements following sequential administration of etomidate and rocuronium was significantly lower in Group O than in Group S (28."	( An, X; Fang, X; Li, C; Sahebally, Z; Wen, X; Zhao, B, 2017)
"In Parkinson's disease, dyskinesias result from disease progression and chronic levodopa therapy."	( Deik, A; Isaacson, S; Jimenez-Shaheed, J; Johnson, R; Malaty, IA; Pahwa, R; Patni, R, 2019)
"In contrast, analysis of abnormal involuntary movements (AIMs) induced by L-DOPA treatment of 6-OHDA-lesioned animals yielded two populations: one with mild LID, and the other with severe LID, which are also related to different therapeutic responses."	( Albarrán-Bravo, S; Ávalos-Fuentes, JA; Cortés, H; Erlij, D; Florán, B; Leyva-García, N; Rangel-Barajas, C; Rodriguez-Sánchez, M, 2019)
"This study analyzed a variety of abnormal movements such as involuntary eye movements, limb and body contractions, and gasping as well as clinical, metabolic, radiologic, and treatment results in 13 infants with nutritional Cbl deficiency."	( Yaramis, A, 2020)
"The risk of graft-induced dyskinesias (GIDs) presents a major challenge in progressing cell transplantation as a therapy for Parkinson's disease."	( Harrison, DJ; Hills, R; Lane, EL; Lelos, MJ; Ramos-Varas, E; Turner, S, 2022)
"l-Dopa-induced dyskinesias (LIDs) are a frequent complication in l-dopa-treated patients affected by Parkinson's disease (PD)."	( Bove, F; Calabresi, P, 2022)
"This hemichorea-hemiballismus case shows dynamic restoration of putamen metabolism mirroring clinical evolution after administration of corticosteroids, suggesting an autoimmune COVID-19 vaccine-induced reaction."	( Batot, C; Chea, M; Degos, B; Mazoyer, J; Mongin, M; Pop, G; Zeidan, S, 2022)
"His symptoms, namely hyperhidrosis and involuntary movements, were not relieved by antiepileptic drug treatment, but responded favorably to high-dose steroid therapy and intravenous immunoglobulin."	( Chen, L; Chen, X; Chen, Y; Jiang, L; Li, X; Qiao, T; Wei, H; Xu, Y, 2022)

Timeframe	Studies, This Condition (%)	All Conditions %
pre-1990	44 (4.65)	23.3326
1990's	12 (1.27)	12.5806
2000's	347 (36.64)	18.1394
2010's	360 (38.01)	28.8240
2020's	184 (19.43)	9.53

Drug	Relationship Strength	Studies	Trials
alpha-hydroxyglutarate	low	1	0
gamma-aminobutyric acid	low	14	0
5-hydroxytryptophan	low	1	0
agmatine	low	2	0
ammonium hydroxide	low	4	0
bromide	low	1	0
carnitine	low	2	0
choline	low	3	0
chlorine	low	1	0
salicylic acid	low	1	0
bupropion	low	1	0
3,4-dihydroxyphenylacetic acid	low	3	0
creatine	low	4	0
lactic acid	low	1	0
glutaric acid	low	1	0
glycine	low	3	0
dihydroxyphenylalanine	medium	10	2
nitrites	low	1	0
nitrous oxide	medium	1	1
phenol	low	2	0
phenethylamine	low	1	0
pyrazinamide	low	1	0
pyridoxine	low	1	0
thiamine	low	1	0
uric acid	low	2	0
urea	low	1	0
8-hydroxy-2-(di-n-propylamino)tetralin	low	2	0
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid	low	1	0
4-iodo-2,5-dimethoxyphenylisopropylamine	low	1	0
ibotenic acid	low	1	0
sk&f-38393	low	1	0
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	low	18	0
3-methoxytyrosine	medium	1	1
4-aminopyridine	medium	2	1
homovanillic acid	low	3	0
phenytoin	low	1	0
hydroxyindoleacetic acid	low	2	0
acetazolamide	low	2	0
albendazole	low	2	0
alendronate	low	1	0
amantadine	medium	20	6
pimagedine	low	1	0
theophylline	low	1	0
dan 2163	low	1	0
baclofen	medium	6	1
benserazide	medium	10	3
berberine	low	1	0
biperiden	low	2	0
bromperidol	low	1	0
buspirone	low	2	0
caffeine	low	6	0
carbamazepine	low	8	0
chlordiazepoxide	low	1	0
chlorpromazine	low	10	0
chlorzoxazone	low	1	0
cilostazol	low	1	0
ciprofloxacin	low	1	0
cisapride	low	1	0
citalopram	low	1	0
clonazepam	low	8	0
clonidine	low	1	0
amphetamine	low	6	0
diazepam	low	2	0
diphenhydramine	low	1	0
valproic acid	low	3	0
donepezil	medium	1	1
droperidol	low	1	0
fenfluramine	low	1	0
fentanyl	low	1	0
fluphenazine	low	1	0
flumazenil	low	2	0
fluorouracil	low	2	0
fluoxetine	low	1	0
gabapentin	low	7	0
glyburide	low	1	0
haloperidol	low	39	0
hydralazine	low	1	0
lidocaine	low	1	0
ifosfamide	low	1	0
indomethacin	low	1	0
iofetamine	low	1	0
isoflurane	low	1	0
isoniazid	low	1	0
isradipine	low	1	0
ketamine	low	4	0
lamotrigine	low	2	0
beta-lapachone	low	1	0
lorazepam	low	2	0
mazindol	low	1	0
mecamylamine	low	1	0
mechlorethamine	low	1	0
memantine	medium	4	1
meperidine	low	1	0
mesoridazine	low	1	0
metformin	low	1	0
methylphenidate	medium	6	1
metoclopramide	low	5	0
metronidazole	low	1	0
mexiletine	low	1	0
mianserin	low	1	0
midazolam	low	1	0
mirtazapine	low	1	0
muscimol	low	2	0
apnea	low	2	0
nifedipine	low	1	0
nimodipine	low	2	0
ns 1619	low	1	0
oxidopamine	low	72	0
oxybutynin	medium	2	1
pentoxifylline	low	1	0
phenindione	low	1	0
phenobarbital	low	1	0
piracetam	low	5	0
pirenzepine	low	1	0
piribedil	low	1	0
probenecid	low	1	0
procainamide	low	1	0
procaine	low	2	0
prochlorperazine	low	2	0
propofol	medium	4	1
propranolol	low	1	0
risperidone	low	7	0
ropinirole	medium	6	1
saccharin	low	1	0
sevoflurane	low	1	0
sulfanilamide	low	1	0
sulpiride	low	4	0
thioridazine	low	1	0
thiotepa	low	1	0
tizanidine	low	1	0
tremorine	low	1	0
trifluoperazine	low	1	0
trihexyphenidyl	low	1	0
zolpidem	low	2	0
zonisamide	medium	5	2
prednisolone	low	2	0
reserpine	low	6	0
prednisone	low	3	0
amifampridine	medium	1	1
alanine	medium	5	3
serine	low	5	0
aspartic acid	low	2	0
glutamine	low	4	0
apomorphine	medium	24	4
tetrabenazine	medium	16	1
kanamycin a	medium	1	1
galactose	low	1	0
carbostyril	low	1	0
levodopa	medium	437	50
tyrosine	medium	1	1
methylene blue	low	2	0
leucine	low	2	0
methionine	low	4	0
phenylalanine	low	1	0
colchicine	low	1	0
cycloserine	low	2	0
valine	low	3	0
threonine	low	1	0
tryptophan	low	1	0
isoleucine	low	1	0
arginine	low	2	0
phencyclidine	low	1	0
isoprene	low	1	0
pantothenic acid	low	1	0
methylprednisolone	low	9	0
rotenone	low	3	0
thiopropazate	low	1	0
phenothiazine	low	5	0
butyl bromide	low	1	0
pyrroles	low	1	0
thiophenes	medium	4	1
piperidine	low	1	0
3,3'-iminodipropionitrile	low	1	0
ergotamine	low	1	0
framycetin	low	1	0
yohimbine	low	1	0
catechin	low	2	0
benzoxazoles	low	2	0
adamantane	low	1	0
isoxazoles	low	1	0
thiazoles	medium	5	1
paraoxon	low	1	0
thioproperazine	low	2	0
fluorobenzenes	low	2	0
bicuculline	low	3	0
alpha-aminopyridine	low	1	0
hesperidin	low	1	0
methamphetamine	low	1	0
aminoacetonitrile	low	1	0
malondialdehyde	low	2	0
congo red	low	1	0
4-amino-3-phenylbutyric acid	low	1	0
d-alpha tocopherol	low	1	0
pimozide	low	1	0
sabinene	low	1	0
trimetazidine	low	1	0
n-methylaspartate	low	3	0
manganese	low	2	0
trolamine salicylate	low	1	0
tiletamine hydrochloride	low	1	0
selegiline	low	1	0
lisuride	medium	1	1
carbimazole	low	1	0
bromocriptine	low	6	0
phenyl acetate	low	3	0
glutamic acid	medium	11	1
tramadol	low	3	0
oxcarbazepine	low	2	0
s-adenosylmethionine	low	1	0
5,7-dihydroxytryptamine	low	1	0
substance p	low	2	0
dobutamine	low	2	0
paroxetine	low	1	0
pergolide	medium	3	1
fomesafen	low	5	0
lovastatin	low	1	0
flupirtine	low	1	0
enoximone	low	1	0
idazoxan	low	1	0
quinpirole	low	2	0
cabergoline	medium	4	2
fluorodopa f 18	medium	6	2
n 0437, (-)-isomer	medium	3	1
remacemide	medium	1	1
aripiprazole	low	2	0
remifentanil	low	2	0
capecitabine	low	1	0
adenosine	low	5	0
3-n-butylphthalide	low	1	0
oseltamivir	low	1	0
5-methylcytosine	low	1	0
epigallocatechin gallate	low	1	0
lissamine rhodamine b sulfonyl chloride	low	1	0
lithium sulfate	low	1	0
triazoles	low	2	0
fluorodeoxyglucose f18	low	9	0
sertraline	low	3	0
fubrogonium	low	1	0
naftazone	medium	1	1
hesperetin	low	1	0
methotrimeprazine	low	1	0
rivastigmine	low	1	0
nicotine	low	3	0
tandospirone	medium	1	1
homocysteine	medium	4	1
carbidopa, levodopa drug combination	medium	12	4
sr141716	low	1	0
way 100135	low	1	0
pramipexole	medium	9	3
5-fluorodopa	low	1	0
rti 121	low	1	0
5-fluorodopamine	low	1	0
ro 8-0576	medium	5	2
dihydrotetrabenazine	low	3	0
galactose-1-phosphate	low	1	0
blonanserin	medium	1	1
safinamide	medium	6	3
proline	low	1	0
besonprodil	low	1	0
ym 09151-2	low	1	0
hydroxyl radical	low	1	0
alpha-methyl-beta-hydroxybutyrate	low	1	0
atropine	low	2	0
ropivacaine	low	1	0
zm 241385	low	2	0
fipamezole	low	1	0
lacosamide	low	1	0
cp 101,606	medium	2	1
benzofurans	low	1	0
potassium bromide	low	1	0
dihydropyridines	low	1	0
n-acetylneuraminic acid	low	1	0
oxytocin	low	1	0
theanine	low	2	0
inositol 3-phosphate	low	3	0
rocuronium	medium	1	1
naringin	low	1	0
tretinoin	low	1	0
resveratrol	low	3	0
cocaine	medium	2	1
eicosapentaenoic acid	medium	1	1
lycopene	low	1	0
y 27632	low	1	0
enkephalin, leucine	low	8	0
glycosides	low	1	0
stilbenes	low	2	0
cannabidiol	low	2	0
etomidate	medium	1	1
cotinine	low	1	0
D-fructopyranose	low	3	0
thioacetamide	low	1	0
nadp	low	1	0
ranitidine	low	1	0
raclopride	low	1	0
quinine	low	1	0
4-(1h-imidazol-4-ylmethyl)piperidine	low	1	0
u-50488	low	1	0
sch 23390	low	1	0
bp 897	low	1	0
2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine	low	1	0
naphthoquinones	medium	2	1
tolcapone	medium	3	2
alpha-linolenic acid	medium	1	1
entacapone	medium	7	3
humulene	medium	2	1
anandamide	low	1	0
glyceryl 2-arachidonate	low	1	0
levomepromazine maleate	low	1	0
levetiracetam	low	5	0
naloxone	low	1	0
oxycodone	medium	1	1
topiramate	low	4	0
morphine	low	2	0
istradefylline	medium	8	1
dexmedetomidine	low	1	0
l 745870	low	1	0
mdl 100907	low	2	0
nateglinide	low	1	0
linarin	low	1	0
fluvoxamine	low	2	0
8-(3-chlorostyryl)caffeine	low	1	0
naltrexone	low	3	0
dextromethorphan	low	1	0
cysteine	low	1	0
phosphorus	low	1	0
norbinaltorphimine	low	1	0
enkephalin, ala(2)-mephe(4)-gly(5)-	low	1	0
naltrindole	low	2	0
cyprodime	low	1	0
tetrodotoxin	low	1	0
selenium	low	1	0
dizocilpine maleate	low	3	0
1,2-dilinolenoyl-3-(4-aminobutyryl)propane-1,2,3-triol	low	1	0
tiglylglycine	low	1	0
trk 820	low	2	0
iem 1460	low	1	0
butylscopolammonium bromide	low	1	0
morphinans	low	3	0
ergoline	medium	4	2
tiapamil hydrochloride	low	1	0
stepholidine	low	1	0
vilazodone hydrochloride	low	2	0
sarizotan	medium	3	1
pardoprunox	low	1	0
sl 327	low	1	0
stalevo	medium	3	2
f 13640	low	2	0
perampanel	low	1	0
mavoglurant	low	1	0
2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane	low	7	0
pimavanserin	low	1	0
linagliptin	low	1	0
alpha-synuclein	low	7	0
oxadiazoles	low	2	0
lactulose	low	3	0
lisdexamfetamine dimesylate	low	1	0
scopolamine hydrobromide	low	1	0
rifamycins	low	1	0
clove	low	1	0
jaw	low	3	0
CDN1163	low	1	0
dynorphins	low	4	0
glucagon-like peptide 1	low	1	0
phosphatidylcholines	low	1	0
calpain	low	1	0
quetiapine fumarate	low	5	0
cardiovascular agents	low	3	0
peptide 31d	low	1	0
piperidines	medium	13	3
exenatide	low	1	0
2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone	low	1	0
ascorbic acid	low	1	0
minocycline	low	1	0
warfarin	low	1	0
phenprocoumon	low	1	0
nitrophenols	medium	3	2
vitamin b 12	low	5	0
acyclovir	low	2	0
levoleucovorin	low	1	0
cyclic gmp	low	1	0
folic acid	low	3	0
guanosine 5'-o-(3-thiotriphosphate)	low	1	0
clozapine	low	8	0
olanzapine	medium	5	1
sildenafil citrate	low	1	0
5-methyltetrahydrofolate	low	1	0
opicapone	low	2	0
eye	low	3	0
carbidopa	medium	43	13
gq1b ganglioside	low	1	0
preproenkephalin	low	6	0

Protein Targets (1,978)

Protein	Potency Measurements	Inhibition Measurements	Activation Measurements	Drugs
Dihydropteridine reductase	0	1	0	1
Amine oxidase [flavin-containing] A	0	15	0	16
Amine oxidase [flavin-containing] B	0	19	3	22
Amine oxidase [flavin-containing] B	0	5	0	7
dopamine D1 receptor	15	0	0	15
GLS protein	71	0	0	71
regulator of G-protein signaling 4	64	0	0	64
euchromatic histone-lysine N-methyltransferase 2	129	0	0	129
DNA polymerase kappa isoform 1	24	0	0	24
histone acetyltransferase KAT2A isoform 1	31	0	0	31
Adenosine receptor A3	0	18	4	23
Adenosine receptor A1	1	19	2	28
Adenosine receptor A3	0	5	0	6
Adenosine receptor A2a	0	16	11	31
Adenosine receptor A2b	0	8	2	15
Adenosine receptor A2b	0	5	2	10
Adenosine receptor A1	0	14	6	25
Adenosine receptor A2a	0	16	4	29
Adenosine receptor A1	0	2	2	4
Mu-type opioid receptor	0	26	7	37
ATP-dependent phosphofructokinase	67	0	0	67
Sodium-dependent dopamine transporter	0	36	4	41
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE	49	0	0	49
Chain A, ATP-DEPENDENT DNA HELICASE Q1	13	0	0	13
nonstructural protein 1	16	0	0	16
thyroid hormone receptor beta isoform a	25	0	0	25
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	16	0	0	16
M-phase phosphoprotein 8	29	0	0	29
lamin isoform A-delta10	87	0	0	87
Glutamate receptor 1	2	5	2	9
Glutamate receptor ionotropic, NMDA 1	0	29	4	38
Glutamate receptor ionotropic, kainate 3	0	5	0	5
Glutamate receptor ionotropic, NMDA 2A	0	27	4	36
Glutamate receptor ionotropic, NMDA 2B	0	29	4	38
Glutamate receptor ionotropic, NMDA 2C	0	27	4	37
Glutamate receptor ionotropic, NMDA 2D	0	26	4	35
Glutamate receptor ionotropic, NMDA 3B	0	26	4	35
Glutamate receptor ionotropic, NMDA 3A	0	26	4	35
Chain A, Penicillin Amidohydrolase	0	2	0	2
Chain B, Penicillin Amidohydrolase	0	2	0	2
Chain A, Penicillin Amidohydrolase	0	2	0	2
Chain B, Penicillin Amidohydrolase	0	2	0	2
Chain A, Penicillin Amidohydrolase	0	2	0	2
Chain B, Penicillin Amidohydrolase	0	2	0	2
Chain A, Penicillin Amidohydrolase	0	2	0	2
Chain B, Penicillin Amidohydrolase	0	2	0	2
Chain A, Penicillin Amidohydrolase	0	2	0	2
Chain B, Penicillin Amidohydrolase	0	2	0	2
Chain A, Penicillin Amidohydrolase	0	2	0	2
Chain B, Penicillin Amidohydrolase	0	2	0	2
Chain A, Penicillin Amidohydrolase	0	2	0	2
Chain B, Penicillin Amidohydrolase	0	2	0	2
Chain A, TYROSYL-DNA PHOSPHODIESTERASE	32	0	0	32
Chain A, HADH2 protein	29	0	0	29
Chain B, HADH2 protein	29	0	0	29
Chain A, JmjC domain-containing histone demethylation protein 3A	19	0	0	19
Chain A, 2-oxoglutarate Oxygenase	39	0	0	39
Chain A, Protocatechuate 3,4-dioxygenase	0	0	1	1
Chain M, Protocatechuate 3,4-dioxygenase	0	0	1	1
Olfactory receptor class A-like protein 1	0	0	1	1
Luciferase	37	0	0	37
endonuclease IV	13	0	0	13
thioredoxin reductase	68	0	0	68
RGS12	1	0	0	1
phosphopantetheinyl transferase	48	0	0	48
NFKB1 protein, partial	27	0	0	27
TDP1 protein	100	0	0	100
Microtubule-associated protein tau	50	0	0	50
Thrombopoietin	19	0	0	19
alkaline phosphatase, intestinal	0	0	1	1
thioredoxin glutathione reductase	13	0	0	13
apical membrane antigen 1, AMA1	6	0	0	6
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)	28	0	0	28
thyroid stimulating hormone receptor	57	0	0	57
hypothetical protein, conserved	5	0	0	5
Bloom syndrome protein isoform 1	42	0	0	42
lysosomal alpha-glucosidase preproprotein	8	0	0	8
peripheral myelin protein 22 isoform 1	27	0	0	27
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein	0	1	0	1
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1	18	0	0	18
intestinal alkaline phosphatase precursor	0	1	0	1
chromobox protein homolog 1	73	0	0	73
guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1	1	0	0	1
DNA polymerase beta	15	0	0	15
flap endonuclease 1	31	0	0	31
DNA polymerase iota isoform a (long)	30	0	0	30
geminin	79	0	0	79
alkaline phosphatase, germ cell type preproprotein	0	0	1	1
POsterior Segregation	0	0	6	6
muscarinic acetylcholine receptor M1	50	0	0	50
Prolyl 4-hydroxylase subunit alpha-1	0	2	0	2
Sodium-dependent noradrenaline transporter	0	46	9	55
Zinc finger protein mex-5	0	0	5	5
Histamine H2 receptor	0	18	2	20
Histamine H4 receptor	0	6	3	9
Histamine H3 receptor	0	1	0	4
Histamine H3 receptor	0	10	1	11
Gamma-aminobutyric acid type B receptor subunit 2	0	3	2	5
Gamma-aminobutyric acid type B receptor subunit 1	0	3	2	5
Chain A, Cruzipain	12	0	0	12
RAR-related orphan receptor gamma	72	0	0	72
USP1 protein, partial	51	0	0	51
aldehyde dehydrogenase 1 family, member A1	55	0	0	55
estrogen receptor 2 (ER beta)	38	0	0	38
cytochrome P450 family 3 subfamily A polypeptide 4	71	0	0	71
glucocorticoid receptor [Homo sapiens]	77	0	0	77
cytochrome P450 2D6	66	0	0	66
glucocerebrosidase	10	0	0	10
IDH1	27	0	0	27
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a	25	0	0	25
cytochrome P450 2D6 isoform 1	43	0	0	43
transcriptional regulator ERG isoform 3	8	0	0	8
thyroid hormone receptor beta isoform 2	79	0	0	79
mitogen-activated protein kinase 1	33	0	0	33
peripheral myelin protein 22	53	0	0	53
survival motor neuron protein isoform d	36	0	0	36
lethal factor (plasmid)	31	0	0	31
Potassium channel subfamily K member 2	0	8	7	15
Rap guanine nucleotide exchange factor 3	6	0	0	6
Cellular tumor antigen p53	59	0	0	59
Potassium voltage-gated channel subfamily A member 3	0	1	1	2
Acetylcholinesterase	0	4	0	4
Pteridine reductase 1	0	1	0	1
Potassium voltage-gated channel subfamily A member 1	0	2	0	2
Potassium voltage-gated channel subfamily H member 2	0	70	0	72
atrial natriuretic peptide receptor 1 precursor	14	0	0	14
5-hydroxytryptamine receptor 1A	0	32	17	50
5-hydroxytryptamine receptor 2C	0	35	6	41
5-hydroxytryptamine receptor 2A	0	40	7	49
5-hydroxytryptamine receptor 1A	0	62	6	72
5-hydroxytryptamine receptor 2A	0	61	8	72
5-hydroxytryptamine receptor 2C	0	66	6	73
5-hydroxytryptamine receptor 1B	0	41	3	45
5-hydroxytryptamine receptor 1D	0	15	3	19
5-hydroxytryptamine receptor 1F	0	15	3	19
5-hydroxytryptamine receptor 2B	0	32	6	38
5-hydroxytryptamine receptor 6	0	5	3	8
5-hydroxytryptamine receptor 7	0	15	3	18
5-hydroxytryptamine receptor 2C	0	5	0	6
5-hydroxytryptamine receptor 2A	0	4	0	5
5-hydroxytryptamine receptor 5A	0	5	3	8
5-hydroxytryptamine receptor 5B	0	5	3	8
5-hydroxytryptamine receptor 3A	0	14	3	17
5-hydroxytryptamine receptor 2B	0	63	4	67
5-hydroxytryptamine receptor 5A	0	6	0	6
5-hydroxytryptamine receptor 4	0	7	4	13
Ataxin-2	47	0	0	47
5-hydroxytryptamine receptor 3B	0	14	3	17
Alpha-1B adrenergic receptor	0	49	7	56
Beta-1 adrenergic receptor	0	7	1	9
Alpha-2B adrenergic receptor	0	31	5	37
Alpha-2C adrenergic receptor	0	31	5	37
Alpha-2A adrenergic receptor	0	32	5	38
Alpha-1D adrenergic receptor	0	42	7	50
Alpha-1A adrenergic receptor	0	52	8	60
Beta-2 adrenergic receptor	0	2	0	2
Chain A, Ferritin light chain	26	0	0	26
arylsulfatase A	51	0	0	51
alpha-galactosidase	9	0	0	9
potassium voltage-gated channel subfamily H member 2 isoform d	47	0	0	47
aryl hydrocarbon receptor	0	0	1	1
nuclear receptor subfamily 1 group I member 2 isoform 1	0	0	1	1
Amine oxidase [flavin-containing] B	0	12	0	13
Guanine nucleotide-binding protein G	10	0	0	10
Amine oxidase [flavin-containing] B	0	2	0	3
mu-type opioid receptor isoform MOR-1	0	0	4	4
5-hydroxytryptamine receptor 2A	0	0	4	4
Gamma-aminobutyric acid receptor subunit pi	52	22	3	77
Cytochrome P450 3A4	0	37	2	42
Neuronal acetylcholine receptor subunit alpha-4	1	10	4	16
Cytochrome P450 2C9	0	31	1	33
Neuronal acetylcholine receptor subunit beta-2	1	10	4	16
D(2) dopamine receptor	0	69	16	94
Gamma-aminobutyric acid receptor subunit beta-1	52	22	3	77
Translocator protein	0	8	2	11
Gamma-aminobutyric acid receptor subunit delta	52	22	3	77
Gamma-aminobutyric acid receptor subunit gamma-2	52	22	5	79
D	0	36	0	39
D(3) dopamine receptor	0	35	2	39
Gamma-aminobutyric acid receptor subunit alpha-5	52	22	3	77
Gamma-aminobutyric acid receptor subunit alpha-3	52	22	3	77
D(2) dopamine receptor	0	15	0	15
Gamma-aminobutyric acid receptor subunit gamma-1	52	22	3	77
Gamma-aminobutyric acid receptor subunit alpha-2	52	22	3	77
Sodium-dependent dopamine transporter	0	33	2	35
Alpha-1D adrenergic receptor	0	46	2	50
5-hydroxytryptamine receptor 1D	0	5	0	7
5-hydroxytryptamine receptor 1B	0	6	2	8
Gamma-aminobutyric acid receptor subunit alpha-4	52	22	3	77
Gamma-aminobutyric acid receptor subunit gamma-3	52	22	3	77
Gamma-aminobutyric acid receptor subunit alpha-6	52	22	3	77
Sodium-dependent serotonin transporter	0	22	2	25
5-hydroxytryptamine receptor 7	0	19	1	20
Alpha-1A adrenergic receptor	0	18	3	23
Alpha-1B adrenergic receptor	0	12	2	16
5-hydroxytryptamine receptor 6	0	39	1	42
5-hydroxytryptamine receptor 7	0	14	0	14
D(2) dopamine receptor	0	58	12	74
Gamma-aminobutyric acid receptor subunit alpha-1	52	22	5	79
Gamma-aminobutyric acid receptor subunit beta-3	52	22	3	77
Gamma-aminobutyric acid receptor subunit beta-2	52	22	5	79
D	0	4	0	4
5-hydroxytryptamine receptor 2A	0	3	0	3
GABA theta subunit	52	22	3	77
Sigma non-opioid intracellular receptor 1	0	51	0	51
Gamma-aminobutyric acid receptor subunit epsilon	52	22	3	77
Lysosomal alpha-glucosidase	0	3	0	3
Transporter	0	22	1	24
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, CARBONIC ANHYDRASE II	0	0	1	1
Chain A, Carbonic Anhydrase Ii	0	0	1	1
Chain A, Carbonic Anhydrase Ii	0	0	1	1
Chain A, Beta-lactamase	26	0	0	26
Chain A, Endochitinase	0	1	0	1
Chain A, Endochitinase	0	1	0	1
Chain A, Endochitinase	0	1	0	1
Chain A, Class Iii Chitinase Chia1	0	1	0	1
Chain A, Carbonic anhydrase 13	0	1	0	1
Chain A, Carbonic anhydrase II	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Chain A, Carbonic anhydrase	0	1	0	1
Chain B, Carbonic anhydrase	0	1	0	1
Chain A, Carbonic anhydrase 2	0	1	0	1
Carbonic anhydrase	0	0	0	5
Carbonic anhydrase	0	6	0	6
GALC protein	15	0	0	15
GLI family zinc finger 3	75	0	0	75
nuclear receptor subfamily 1, group I, member 3	67	0	0	67
retinoic acid nuclear receptor alpha variant 1	69	0	0	69
retinoid X nuclear receptor alpha	53	0	0	53
estrogen-related nuclear receptor alpha	79	0	0	79
Carbonic anhydrase	0	6	0	6
Carbonic anhydrase	0	6	0	6
Carbonic anhydrase	0	6	0	6
nuclear factor erythroid 2-related factor 2 isoform 1	65	0	0	65
muscleblind-like protein 1 isoform 1	16	0	0	16
ATP-binding cassette sub-family C member 3	0	80	0	80
Multidrug resistance-associated protein 4	0	81	0	83
Carbonic anhydrase	0	5	0	5
Solute carrier family 22 member 6	0	7	0	8
Carbonic anhydrase 12	0	16	1	26
Prolyl endopeptidase	0	3	0	3
Carbonic anhydrase-related protein 11	0	1	0	3
Bile salt export pump	0	122	0	122
Glycogen phosphorylase, muscle form	0	2	0	2
Renin	0	5	0	5
Carbonic anhydrase 1	0	31	1	50
Carbonic anhydrase 2	0	31	4	52
Carbonic anhydrase 2	0	4	1	5
Cytochrome P450 1A2	0	18	2	20
Carbonic anhydrase 3	0	14	1	22
Cathepsin B	0	1	0	1
Steryl-sulfatase	0	1	0	1
Polyunsaturated fatty acid 5-lipoxygenase	0	4	0	4
Cytochrome P450 2C8	0	5	0	5
Cytochrome P450 2D6	0	32	3	38
Cytochrome P450 2A6	0	9	1	10
Androgen receptor	0	9	0	9
Cannabinoid receptor 1	0	8	3	11
Arachidonate 5-lipoxygenase-activating protein	0	3	0	3
Cytochrome P450 2B6	0	4	1	7
Carbonic anhydrase 4	0	19	1	28
Carbonic anhydrase 6	0	18	1	27
Carbonic anhydrase 5A, mitochondrial	0	3	0	3
Serum paraoxonase/arylesterase 1	0	3	0	3
Dipeptidyl peptidase 4	0	5	2	8
Endochitinase	0	1	0	1
Delta-type opioid receptor	0	29	4	42
Cytochrome P450 2C19	0	17	1	19
Delta-type opioid receptor	0	24	4	32
Mu-type opioid receptor	0	27	5	36
Carbonic anhydrase 5A, mitochondrial	0	16	3	29
Carbonic anhydrase	0	6	0	10
Kappa-type opioid receptor	0	18	3	26
Carbonic anhydrase 7	0	15	1	24
Carbonic anhydrase	0	1	0	1
D(1A) dopamine receptor	14	5	0	19
Corticosteroid 11-beta-dehydrogenase isozyme 1	0	1	0	1
Carbonic anhydrase	0	6	0	10
Cholinesterase	0	12	1	13
Carbonic anhydrase	0	5	0	5
Fatty-acid amide hydrolase 1	0	6	0	7
Beta-carbonic anhydrase 1	0	7	0	7
Carbonic anhydrase 2	0	6	0	6
Squalene synthase	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-7	0	9	3	13
Carbonic anhydrase 9	0	17	1	28
Carbonic anhydrase	0	3	0	3
Carbonic anhydrase, alpha family	0	6	0	6
Carbonic anhydrase	0	6	0	10
Carbonic anhydrase 3	0	5	0	5
Carbonic anhydrase	0	3	0	8
Carbonic anhydrase	0	7	0	12
Carbonic anhydrase	0	6	0	6
Sigma intracellular receptor 2	0	8	0	8
Delta carbonic anhydrase	0	6	0	6
Sigma non-opioid intracellular receptor 1	0	17	0	17
Renin	0	1	0	1
Carbonic anhydrase	0	5	0	9
Endochitinase A1	0	1	0	1
Multidrug resistance-associated protein 1	0	1	0	1
Carbonic anhydrase 13	0	11	1	14
Canalicular multispecific organic anion transporter 1	0	79	0	79
Carbonic anhydrase 4	0	6	0	8
Carbonic anhydrase 15	0	13	0	18
Acidic mammalian chitinase	0	1	0	1
Carbonic anhydrase 13	0	7	0	15
Carbonic anhydrase 7	0	1	0	1
Carbonic anhydrase	0	1	0	1
Carbonic anhydrase 14	0	13	1	23
Carbonic anhydrase	0	1	0	1
Carbonic anhydrase 2, isoform A	0	1	0	1
Carbonic anhydrase 5B, mitochondrial	0	14	1	25
acetylcholinesterase	42	0	0	42
15-lipoxygenase, partial	22	0	0	22
pregnane X receptor	9	0	0	9
AR protein	103	0	0	103
farnesoid X nuclear receptor	36	0	0	36
estrogen nuclear receptor alpha	110	0	0	110
vitamin D (1,25- dihydroxyvitamin D3) receptor	51	0	0	51
D(1A) dopamine receptor	42	0	0	42
heat shock protein beta-1	24	0	0	24
Histone deacetylase 3	0	4	0	4
Histone deacetylase 4	0	4	0	4
Histone deacetylase 1	0	6	0	6
Histone deacetylase 7	0	4	0	4
Histone deacetylase 2	0	5	0	5
Polyamine deacetylase HDAC10	0	4	0	4
Histone deacetylase 11	0	4	0	4
Histone deacetylase 8	0	4	0	4
Histone deacetylase 6	0	6	0	6
Histone deacetylase 9	0	4	0	4
Histone deacetylase 5	0	4	0	4
Chain E, Purine nucleoside phosphorylase	0	1	0	1
Thymidine kinase	0	1	0	1
Smad3	17	0	0	17
EWS/FLI fusion protein	52	0	0	52
activating transcription factor 6	24	0	0	24
Histone H2A.x	27	0	0	27
hemoglobin subunit beta	4	0	0	4
ubiquitin carboxyl-terminal hydrolase 2 isoform a	11	0	0	11
Solute carrier family 22 member 1	0	27	0	34
Bile salt export pump	0	20	0	20
Purine nucleoside phosphorylase	0	2	0	2
Thymidine kinase, cytosolic	0	0	0	1
POU domain, class 2, transcription factor 2	0	1	0	2
Cytochrome P450 2J2	0	18	0	19
Disintegrin and metalloproteinase domain-containing protein 17	9	1	0	10
Purine nucleoside phosphorylase	0	0	1	1
Solute carrier family 22 member 6	0	5	0	8
Thymidine kinase	0	1	0	1
Solute carrier family 22 member 8	0	6	0	7
Thymidine kinase	0	1	0	1
Chain A, Membrane lipoprotein tmpC	0	0	1	1
Chain A, Membrane lipoprotein tmpC	0	0	1	1
Chain A, Membrane lipoprotein tmpC	0	0	1	1
Chain A, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain B, Structure of PAE2307 in complex with adenosine	0	0	1	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, ADENOSINE RECEPTOR A2A	0	1	0	1
Chain A, tRNA (guanine-N(1)-)-methyltransferase	0	0	1	1
Chain A, Uncharacterized protein MJ0883	0	0	1	1
signal transducer and activator of transcription 6, interleukin-4 induced	2	0	0	2
NPYLR7B	0	0	2	2
glycogen synthase kinase-3 beta isoform 1	0	0	1	1
nuclear receptor ROR-gamma isoform 1	34	0	0	34
high affinity choline transporter 1 isoform a	0	1	0	1
Sodium/nucleoside cotransporter 1	0	2	0	2
Calcium dependent protein kinase	0	1	0	1
Mitogen-activated protein kinase kinase kinase 7	0	0	1	1
Sodium/nucleoside cotransporter 2	0	2	0	2
Voltage-dependent calcium channel gamma-2 subunit	38	0	0	38
Epidermal growth factor receptor	0	9	0	9
Phosphoglycerate kinase 1	0	1	0	1
Adenosine deaminase	0	0	0	1
Avidin	0	0	1	1
Adenosine deaminase	0	0	0	1
Glyceraldehyde-3-phosphate dehydrogenase	0	3	0	3
Receptor tyrosine-protein kinase erbB-2	0	3	0	3
Insulin receptor	0	0	0	1
Phosphoglycerate kinase 2	0	1	0	1
Heat shock protein HSP 90-alpha	0	2	2	4
Platelet-derived growth factor receptor beta	0	0	0	1
Heat shock 70 kDa protein 1A	0	1	0	1
Heat shock cognate 71 kDa protein	0	0	1	1
Fibroblast growth factor receptor 1	0	0	0	1
Inosine-5'-monophosphate dehydrogenase 2	0	1	0	1
Endoplasmin	0	1	1	2
Glutamate receptor 2	40	4	2	46
Inosine-5'-monophosphate dehydrogenase 1	0	1	0	1
Fibroblast growth factor receptor 2	0	0	0	1
Fibroblast growth factor receptor 4	0	0	0	1
Fibroblast growth factor receptor 3	0	0	0	1
Streptavidin	0	0	1	1
Adenosylhomocysteinase	0	0	0	1
Adenylate kinase 2, mitochondrial	0	1	0	1
Adenylate kinase isoenzyme 1	0	1	0	1
Phosphatidylinositol 4-kinase alpha	0	3	0	4
Adenosine kinase	0	0	0	1
Adenosine deaminase	0	0	0	1
Equilibrative nucleoside transporter 2	0	2	0	2
Phosphatidylinositol 4-kinase type 2-beta	0	3	0	4
Histone-lysine N-methyltransferase, H3 lysine-79 specific	0	1	0	1
Equilibrative nucleoside transporter 1	0	2	0	2
Phosphatidylinositol 4-kinase type 2-alpha	0	3	0	4
Solute carrier family 28 member 3	0	2	0	2
Adenosine kinase	0	1	0	2
Phosphatidylinositol 4-kinase beta	0	3	0	4
5-methylthioadenosine/S-adenosylhomocysteine deaminase	0	0	0	1
Adenosine transporter 1	0	0	0	1
Solute carrier family 22 member 2	0	8	0	13
Polyamine oxidase 1	0	1	0	1
Solute carrier family 22 member 3	0	4	0	5
Solute carrier family 22 member 3	0	2	0	3
Nischarin	0	5	0	5
Solute carrier family 22 member 1	0	13	0	17
Deoxyhypusine synthase	0	1	0	1
Solute carrier family 22 member 2	0	10	0	13
Alanine racemase, biosynthetic	0	0	0	1
Proton-coupled amino acid transporter 1	0	10	0	11
Adenosine deaminase	0	0	0	1
glp-1 receptor, partial	24	0	0	24
hypoxia-inducible factor 1 alpha subunit	32	0	0	32
ATAD5 protein, partial	44	0	0	44
Fumarate hydratase	27	0	0	27
caspase 7, apoptosis-related cysteine protease	16	0	0	16
progesterone receptor	48	0	0	48
pregnane X nuclear receptor	65	0	0	65
polyprotein	27	0	0	27
67.9K protein	18	0	0	18
peroxisome proliferator activated receptor gamma	46	0	0	46
caspase-3	16	0	0	16
aryl hydrocarbon receptor	31	0	0	31
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a	48	0	0	48
v-jun sarcoma virus 17 oncogene homolog (avian)	36	0	0	36
nuclear receptor subfamily 1, group I, member 2	7	0	0	7
cellular tumor antigen p53 isoform a	21	0	0	21
nuclear factor erythroid 2-related factor 2 isoform 2	20	0	0	20
histone deacetylase 9 isoform 3	7	0	0	7
urokinase-type plasminogen activator precursor	12	0	0	12
plasminogen precursor	12	0	0	12
urokinase plasminogen activator surface receptor precursor	12	0	0	12
Vif	0	1	0	2
DNA dC->dU-editing enzyme APOBEC-3G isoform 1	4	1	0	5
neuropeptide S receptor isoform A	21	0	0	21
Interferon beta	55	0	0	55
Integrin beta-3	19	0	1	20
Integrin alpha-IIb	19	0	1	20
Methionine aminopeptidase	0	1	0	1
Inositol monophosphatase 1	24	0	0	24
ATPase family AAA domain-containing protein 5	22	0	0	22
Chain A, farnesyl pyrophosphate synthase	0	1	0	1
Geranylgeranyl pyrophosphate synthase	0	1	0	1
Farnesyl pyrophosphate synthase	0	2	0	2
Acetylcholinesterase	0	23	3	27
Hypoxanthine-guanine phosphoribosyltransferase	0	1	0	1
Farnesyl pyrophosphate synthase	0	1	0	1
Farnesyl pyrophosphate synthase	0	1	0	1
thyroid stimulating hormone receptor	36	0	0	36
Botulinum neurotoxin type A	0	1	0	1
Neutrophil cytosol factor 1	0	2	0	2
Nitric oxide synthase, endothelial	0	2	0	2
Nitric oxide synthase, brain	0	3	0	4
Nitric oxide synthase, brain	0	1	0	2
Nitric oxide synthase, inducible	0	2	1	5
Tyrosine-protein kinase	0	0	1	1
Methylcytosine dioxygenase TET2	0	1	1	2
WRN	2	0	0	2
SMAD family member 2	17	0	0	17
SMAD family member 3	17	0	0	17
peroxisome proliferator-activated receptor delta	34	0	0	34
Caspase-7	7	0	0	7
phospholipase A2 precursor	0	1	0	1
vitamin D3 receptor isoform VDRA	38	0	0	38
caspase-3	7	0	0	7
importin subunit beta-1 isoform 1	9	0	0	9
serine/threonine-protein kinase PLK1	4	0	0	4
snurportin-1	9	0	0	9
DNA polymerase eta isoform 1	7	0	0	7
cysteine protease ATG4B isoform a	0	1	0	1
lethal(3)malignant brain tumor-like protein 1 isoform I	3	0	0	3
cytochrome P450 3A4 isoform 1	52	0	0	52
DNA dC->dU-editing enzyme APOBEC-3F isoform a	2	0	0	2
Free fatty acid receptor 1	0	0	1	1
Polyunsaturated fatty acid lipoxygenase ALOX15B	20	0	0	20
Prostaglandin G/H synthase 1	0	4	0	5
Nuclear receptor subfamily 1 group I member 2	0	0	5	5
Trypsin	0	2	0	2
Coagulation factor VII	0	2	0	2
Aromatase	0	7	0	7
Tissue factor	0	4	0	4
Prostaglandin G/H synthase 1	0	8	0	8
Peroxisome proliferator-activated receptor gamma	0	1	4	5
Histamine H2 receptor	41	1	0	48
Prostaglandin G/H synthase 2	0	6	0	6
Free fatty acid receptor 4	0	0	1	1
putative alpha-glucosidase	1	0	0	1
Glutamate receptor ionotropic, NMDA 2D	0	11	0	11
Glutamate receptor ionotropic, NMDA 3B	0	11	0	11
Matrix protein 2	0	1	1	2
Matrix protein 2	0	1	2	3
Spike glycoprotein	51	2	3	56
Glutamate receptor ionotropic, NMDA 1	0	14	0	14
Glutamate receptor ionotropic, NMDA 2A	0	14	0	14
Glutamate receptor ionotropic, NMDA 2B	0	15	0	15
Glutamate receptor ionotropic, NMDA 2C	0	11	0	11
Glutamate receptor ionotropic, NMDA 3A	0	11	0	11
Multidrug and toxin extrusion protein 1	0	9	0	9
parathyroid hormone/parathyroid hormone-related peptide receptor precursor	10	0	0	10
POU domain, class 2, transcription factor 1	0	1	0	3
Phenylethanolamine N-methyltransferase	0	3	0	3
Substance-P receptor	0	3	0	3
Cytochrome P450 2A5	0	4	0	4
Beta-2 adrenergic receptor	0	5	1	8
Sigma non-opioid intracellular receptor 1	0	15	1	16
Fatty-acid amide hydrolase 1	0	4	0	4
Fatty-acid amide hydrolase 1	0	1	0	2
Potassium channel subfamily K member 3	0	4	0	4
Fatty acid-binding protein, liver	0	4	0	4
Glutamate receptor 3	2	4	2	8
Glutamate receptor 4	2	4	2	8
Cannabinoid receptor 1	0	10	3	19
Cannabinoid receptor 2	0	6	3	14
Cannabinoid receptor 1	0	4	1	5
Cannabinoid receptor 2	0	2	1	3
Fatty acid-binding protein 5	0	0	1	1
Corticotropin-releasing factor receptor 2	0	1	0	1
Lanosterol 14-alpha demethylase	0	4	0	4
Potassium channel subfamily K member 2	0	2	0	2
Transient receptor potential cation channel subfamily V member 1	0	1	2	4
Cannabinoid receptor 2	0	2	0	2
Transient receptor potential cation channel subfamily V member 2	0	3	1	4
Chain A, Putative fructose-1,6-bisphosphate aldolase	20	0	0	20
cytochrome P450 2C19 precursor	29	0	0	29
cytochrome P450 2C9 precursor	28	0	0	28
Tryptophan 5-hydroxylase 1	0	6	0	6
D(1A) dopamine receptor	0	43	8	56
D(4) dopamine receptor	0	33	7	47
D(1B) dopamine receptor	0	14	1	19
D(1B) dopamine receptor	0	20	0	20
D(4) dopamine receptor	0	22	1	23
D(3) dopamine receptor	0	58	10	77
E3 ubiquitin-protein ligase Mdm2	0	1	0	1
D	0	13	0	13
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN	0	0	1	1
Nitric oxide synthase, endothelial	0	0	0	2
Nitric oxide synthase, inducible	0	3	0	4
Cationic amino acid transporter 3	0	1	0	1
5-hydroxytryptamine receptor 3E	0	8	1	9
PPM1D protein	15	0	0	15
G	42	0	0	42
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)	11	0	0	11
5-hydroxytryptamine receptor 3A	0	2	1	3
5-hydroxytryptamine receptor 3B	0	8	1	9
HLA class I histocompatibility antigen, B alpha chain	42	0	0	42
ATP-dependent translocase ABCB1	0	30	0	40
Alpha-2C adrenergic receptor	0	48	6	55
Muscarinic acetylcholine receptor M3	0	37	3	43
Histamine H1 receptor	0	7	1	9
Sodium-dependent serotonin transporter	0	47	6	53
Histamine H1 receptor	0	34	4	40
5-hydroxytryptamine receptor 3A	0	12	1	13
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	5	0	5
5-hydroxytryptamine receptor 3D	0	8	1	9
Multidrug and toxin extrusion protein 2	0	4	0	4
5-hydroxytryptamine receptor 3C	0	8	1	9
Inositol hexakisphosphate kinase 1	42	0	0	42
cytochrome P450 2C9, partial	42	0	0	42
Chain A, Hyaluronidase, phage associated	0	1	0	1
Polyphenol oxidase 2	0	6	0	11
Pancreatic alpha-amylase	0	2	0	2
Albumin	0	1	1	3
Urease	0	1	0	1
Prolyl 4-hydroxylase subunit alpha-1	0	0	0	1
Tyrosinase	0	4	0	4
Alpha-2B adrenergic receptor	0	49	3	53
Hyaluronate lyase	0	1	0	1
Prolyl hydroxylase EGLN2	0	0	0	1
Egl nine homolog 1	0	0	0	1
Prolyl hydroxylase EGLN3	0	0	0	1
Hypoxia-inducible factor 1-alpha inhibitor	0	0	0	1
Solute carrier family 23 member 1	0	1	0	1
Metabotropic glutamate receptor 6	0	1	2	4
Excitatory amino acid transporter 4	0	2	0	2
Glutamate transporter homolog	0	0	1	1
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase	0	1	0	1
Excitatory amino acid transporter 1	0	3	0	4
Excitatory amino acid transporter 2	0	3	0	4
Excitatory amino acid transporter 3	0	3	0	4
Metabotropic glutamate receptor 1	0	2	2	5
Metabotropic glutamate receptor 2	0	2	3	6
Carbonic anhydrase-like protein, putative	0	0	0	7
cystic fibrosis transmembrane conductance regulator	0	1	0	1
short transient receptor potential channel 6 isoform 1	0	0	2	2
5-hydroxytryptamine receptor 4	0	51	1	52
Muscarinic acetylcholine receptor M2	0	34	4	43
Muscarinic acetylcholine receptor M4	0	36	2	41
Muscarinic acetylcholine receptor M1	0	17	2	21
Muscarinic acetylcholine receptor M3	0	15	2	19
Muscarinic acetylcholine receptor M4	0	15	2	19
Muscarinic acetylcholine receptor M5	0	15	2	19
Muscarinic acetylcholine receptor M5	0	35	1	39
Muscarinic acetylcholine receptor M2	0	17	3	23
Muscarinic acetylcholine receptor M1	0	38	5	49
Muscarinic acetylcholine receptor M1	0	1	1	4
Muscarinic acetylcholine receptor M4	0	3	1	5
Reverse transcriptase/RNaseH	0	1	0	2
Muscarinic acetylcholine receptor	0	2	2	5
Gamma-aminobutyric acid type B receptor subunit 2	0	3	0	3
Gamma-aminobutyric acid type B receptor subunit 1	0	2	0	2
serine/threonine-protein kinase mTOR isoform 1	24	0	0	24
Zinc finger protein mex-5	0	0	1	1
Genome polyprotein	0	1	0	1
Replicase polyprotein 1ab	0	10	3	13
Hexokinase-2	0	1	0	1
Telomerase reverse transcriptase	0	2	0	2
Acetylcholinesterase	0	14	1	15
Lysine-specific histone demethylase 1A	0	4	0	4
Neuraminidase	0	3	0	3
Neuraminidase	0	2	0	2
Cholinesterase	0	16	0	16
Tyrosine-protein phosphatase non-receptor type 1	0	4	0	6
Aldo-keto reductase family 1 member C3	0	3	0	3
Prolyl endopeptidase	0	3	0	3
Aldo-keto reductase family 1 member C2	0	2	0	2
Cytochrome P450 1B1	0	8	0	8
Prolyl endopeptidase	0	2	0	2
Lysine-specific demethylase 4E	0	2	0	2
Parkin	11	0	0	11
galactokinase	2	0	0	2
hexokinase-4 isoform 1	4	0	0	4
glucokinase regulatory protein	4	0	0	4
atrial natriuretic peptide receptor 2 precursor	15	0	0	15
ras-related protein Rab-9A	19	0	0	19
Cocaine esterase	0	3	0	3
Tyrosyl-DNA phosphodiesterase 2	0	1	0	1
Amyloid-beta precursor protein	2	9	1	12
60 kDa chaperonin	0	3	0	3
Replicase polyprotein 1ab	0	6	4	10
60 kDa heat shock protein, mitochondrial	0	3	0	3
Indoleamine 2,3-dioxygenase 1	0	3	0	4
NAD	0	1	0	1
NADPH--cytochrome P450 reductase	0	1	0	1
Protein kinase C alpha type	0	1	1	2
Nuclear factor NF-kappa-B p105 subunit	0	2	0	2
Protein-glutamine gamma-glutamyltransferase 2	0	1	0	1
Liver carboxylesterase 1	0	3	0	7
Caspase-1	0	1	1	3
M-phase inducer phosphatase 1	0	2	0	2
Alpha-synuclein	3	6	0	9
Tyrosine-protein kinase JAK3	0	1	0	1
10 kDa heat shock protein, mitochondrial	0	3	0	3
Nuclear factor NF-kappa-B p100 subunit	0	2	0	2
Transcription factor p65	0	2	0	2
Receptor-type tyrosine-protein phosphatase eta	0	1	0	1
Thiosulfate sulfurtransferase	0	3	0	3
Receptor protein-tyrosine kinase	0	1	0	1
60 kDa chaperonin	0	3	0	3
10 kDa chaperonin	0	3	0	3
Single-stranded DNA cytosine deaminase	4	0	0	4
Mucosa-associated lymphoid tissue lymphoma translocation protein 1	0	2	0	2
phosphoglycerate kinase	4	0	0	4
Gamma-aminobutyric acid receptor subunit pi	0	12	0	12
Gamma-aminobutyric acid receptor subunit delta	0	12	0	12
Gamma-aminobutyric acid receptor subunit alpha-1	0	16	9	25
Gamma-aminobutyric acid receptor subunit beta-1	0	13	3	16
Gamma-aminobutyric acid receptor subunit gamma-2	0	16	8	24
Gamma-aminobutyric acid receptor subunit beta-3	0	15	5	20
Gamma-aminobutyric acid receptor subunit alpha-5	0	14	7	21
Gamma-aminobutyric acid receptor subunit alpha-3	0	14	6	20
Gamma-aminobutyric acid receptor subunit alpha-2	0	14	6	20
Gamma-aminobutyric acid receptor subunit beta-2	0	14	7	21
Gamma-aminobutyric acid receptor subunit alpha-4	0	13	3	16
Gamma-aminobutyric acid receptor subunit epsilon	0	12	0	12
Gamma-aminobutyric acid receptor subunit alpha-6	0	13	3	16
Gamma-aminobutyric acid receptor subunit gamma-1	0	12	0	12
Gamma-aminobutyric acid receptor subunit gamma-3	0	12	0	12
Gamma-aminobutyric acid receptor subunit theta	0	12	0	12
Alpha-2A adrenergic receptor	0	53	7	61
D(3) dopamine receptor	0	2	1	3
Genome polyprotein	0	2	1	3
ATP-dependent translocase ABCB1	0	7	0	7
Beta-1 adrenergic receptor	0	11	1	12
ATP-dependent translocase ABCB1	0	7	0	7
N-acetyltransferase Eis	0	5	0	5
Acetylcholine receptor subunit alpha	0	3	2	5
Acetylcholine receptor subunit gamma	0	3	2	5
Integrin alpha-5	0	1	0	1
Acetylcholine receptor subunit beta	0	3	2	5
UDP-glucuronosyltransferase 2B7	0	5	0	8
Neuronal acetylcholine receptor subunit beta-2	0	5	1	8
UDP-glucuronosyltransferase 1-6	0	4	0	5
UDP-glucuronosyltransferase 1A1	0	4	0	5
UDP-glucuronosyltransferase 1A4	0	3	0	7
Neuronal acetylcholine receptor subunit beta-4	0	4	1	7
Neuronal acetylcholine receptor subunit alpha-3	0	4	1	5
UDP-glucuronosyltransferase 2B10	0	3	0	3
Neuronal acetylcholine receptor subunit alpha-7	0	5	3	8
Neuronal acetylcholine receptor subunit alpha-4	0	4	1	7
Acetylcholine receptor subunit delta	0	3	2	5
Beta-2 adrenergic receptor	0	7	0	8
Angiotensin-converting enzyme	0	3	0	3
Beta-3 adrenergic receptor	0	5	0	5
Alpha-2A adrenergic receptor	0	2	0	2
Chain A, Glycogen Phosphorylase	0	1	0	1
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Glycogen phosphorylase, liver form	0	0	2	2
Chain A, Chitinase	0	1	0	1
Glycogen phosphorylase, liver form	0	1	0	1
Glycogen phosphorylase, muscle form	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	7	0	7
Vasopressin V2 receptor	0	0	0	2
Serine/threonine-protein kinase mTOR	0	2	0	2
Adenosine receptor A2a	0	2	0	2
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform	0	2	0	2
DNA-dependent protein kinase catalytic subunit	0	2	0	2
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	1	0	1
Adenylate cyclase type 1	0	1	0	3
Chitotriosidase-1	0	4	1	5
Serine-protein kinase ATM	0	1	0	1
Serine/threonine-protein kinase ATR	0	1	0	1
Adenosine receptor A2b	0	1	0	3
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	1	0	1
Palmitoleoyl-protein carboxylesterase NOTUM	0	1	3	4
Endochitinase B1	0	4	1	5
Phosphodiesterase	0	1	0	1
Broad substrate specificity ATP-binding cassette transporter ABCG2	0	6	0	6
Guanine deaminase	0	2	0	2
L-lactate dehydrogenase A chain	0	1	0	1
Cytochrome P450 1A1	0	3	0	3
Cytochrome P450 2C11	0	1	0	1
Steroid 17-alpha-hydroxylase/17,20 lyase	0	1	0	1
Cytochrome P450 3A5	0	1	0	1
Cytochrome P450 3A7	0	1	0	1
Mu-type opioid receptor	0	31	16	57
Delta-type opioid receptor	0	26	12	47
Kappa-type opioid receptor	0	27	12	51
N-acylethanolamine-hydrolyzing acid amidase	0	1	0	1
Heat sensitive channel TRPV3	0	1	1	2
Sigma intracellular receptor 2	0	2	0	2
Transient receptor potential cation channel subfamily A member 1	0	2	1	3
Transient receptor potential cation channel subfamily M member 8	0	1	0	1
Transient receptor potential cation channel subfamily V member 4	0	2	1	3
G-protein coupled receptor 55	0	0	2	2
Diacylglycerol lipase-alpha	0	1	0	1
Vpr	3	0	0	3
Albumin	0	0	11	11
Major prion protein	0	0	3	3
Sodium channel protein type 1 subunit alpha	0	7	0	7
Sodium channel protein type 2 subunit alpha	0	9	0	9
Sodium channel protein type 3 subunit alpha	0	7	0	7
Sodium channel protein type 4 subunit alpha	0	10	0	13
Sodium channel protein type 9 subunit alpha	0	14	0	14
Frizzled-8	0	0	1	1
P2X purinoceptor 4	0	3	0	3
Lactoperoxidase	0	2	0	2
Chain A, serum paraoxonase	0	1	0	1
Poly [ADP-ribose] polymerase tankyrase-2	0	1	0	1
Solute carrier family 22 member 5	0	0	0	1
Solute carrier family 22 member 5	0	0	0	1
Solute carrier family 22 member 16	0	0	0	1
Solute carrier family 22 member 21	0	0	0	1
Solute carrier family 22 member 5	0	0	0	1
Arginase	0	2	0	2
Pancreatic triacylglycerol lipase	0	2	0	2
Prothrombin	0	1	2	3
Prostaglandin G/H synthase 1	0	3	2	6
Aldo-keto reductase family 1 member B1	0	40	0	40
Sucrase-isomaltase, intestinal	0	2	0	2
Prostaglandin G/H synthase 2	0	9	1	10
Xanthine dehydrogenase/oxidase	0	1	0	1
Melatonin receptor type 1A	0	0	1	1
Melatonin receptor type 1B	0	0	1	1
Death-associated protein kinase 1	0	1	0	1
Beta-secretase 1	0	4	0	4
Dihydroorotate dehydrogenase	0	1	0	1
TAR DNA-binding protein 43	13	0	0	13
Gamma-aminobutyric acid receptor subunit alpha-1	0	6	0	7
Gamma-aminobutyric acid receptor subunit beta-1	0	6	0	7
Gamma-aminobutyric acid receptor subunit alpha-2	0	6	0	7
Gamma-aminobutyric acid receptor subunit alpha-3	0	6	0	7
Gamma-aminobutyric acid receptor subunit alpha-4	0	6	0	7
Gamma-aminobutyric acid receptor subunit gamma-2	0	6	0	7
Cholecystokinin receptor type A	0	3	0	3
Gastrin/cholecystokinin type B receptor	0	4	0	4
Proteasome subunit beta type-11	0	0	0	1
NADPH oxidase 1	0	4	0	4
Snq2p	0	0	0	7
Adenylate cyclase type 1	0	4	0	4
Spike glycoprotein	0	2	3	5
Replicase polyprotein 1ab	0	3	3	6
Proteasome subunit alpha type-7	0	0	0	1
Transmembrane protease serine 2	0	2	3	5
Transient receptor potential cation channel subfamily V member 1	0	2	0	2
Voltage-dependent L-type calcium channel subunit alpha-1F	0	20	0	20
Albumin	0	3	8	12
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1	0	4	0	4
Major prion protein	0	0	1	1
Tyrosine-protein kinase Fyn	0	7	0	7
Procathepsin L	0	3	3	6
Replicase polyprotein 1a	0	2	3	5
Replicase polyprotein 1ab	0	2	3	5
Cys-loop ligand-gated ion channel	0	1	0	1
Calmodulin-1	0	4	2	6
Polyunsaturated fatty acid lipoxygenase ALOX15	0	8	0	8
Angiotensin-converting enzyme	0	30	0	30
Sphingomyelin phosphodiesterase	0	1	0	1
Proteasome subunit beta type-1	0	0	0	1
Substance-K receptor	0	8	0	8
Adenylate cyclase type 3	0	4	0	4
Proteasome subunit alpha type-1	0	0	0	1
Proteasome subunit alpha type-2	0	0	0	1
Proteasome subunit alpha type-3	0	0	0	1
Proteasome subunit alpha type-4	0	0	0	1
Adenylate cyclase type 2	0	4	0	4
Adenylate cyclase type 4	0	4	0	4
Proteasome subunit beta type-8	0	0	0	1
Proteasome subunit beta type-9	0	0	0	1
Proteasome subunit alpha type-5	0	0	0	1
Proteasome subunit beta type-4	0	0	0	1
Proteasome subunit beta type-6	0	0	0	1
Proteasome subunit beta type-5	0	1	0	2
Trypanothione reductase	0	6	0	6
Melanocortin receptor 4	0	2	0	2
Melanocortin receptor 5	0	6	0	6
Pleiotropic ABC efflux transporter of multiple drugs	0	7	0	14
Sodium channel protein type 1 subunit alpha	0	7	0	7
Adenylate cyclase type 8	0	4	0	4
Proteasome subunit beta type-10	0	0	0	1
Melanocortin receptor 3	0	2	0	2
Proteasome subunit beta type-3	0	0	0	1
Proteasome subunit beta type-2	0	0	0	1
Gastrin/cholecystokinin type B receptor	0	3	0	3
Proteasome subunit alpha type-6	0	0	2	3
Calmodulin	0	1	3	4
Aldehyde oxidase 1	0	1	0	1
Sodium channel protein type 7 subunit alpha	0	5	0	5
Voltage-dependent L-type calcium channel subunit alpha-1D	0	20	0	20
Adenylate cyclase type 6	0	4	0	4
Adenylate cyclase type 5	0	4	0	4
Aldehyde oxidase	0	2	0	4
Voltage-dependent L-type calcium channel subunit alpha-1S	0	20	0	20
Voltage-dependent L-type calcium channel subunit alpha-1C	0	24	0	25
Sodium channel protein type 5 subunit alpha	0	15	0	15
Nuclear receptor subfamily 3 group C member 3	0	29	0	29
Adenylyl cyclase 7	0	4	0	4
Proteasome subunit alpha-type 8	0	0	0	1
Sodium channel protein type 2 subunit alpha	0	8	0	8
Proteasome subunit beta type-7	0	0	0	1
Angiotensin-converting enzyme 2	0	2	3	5
Sodium channel protein type 3 subunit alpha	0	9	0	9
Sodium channel protein type 11 subunit alpha	0	5	0	5
Sodium channel protein type 8 subunit alpha	0	5	0	5
Sodium channel protein type 10 subunit alpha	0	6	0	6
bromodomain adjacent to zinc finger domain 2B	22	0	0	22
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Acetylcholinesterase	0	0	1	1
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein	0	0	1	1
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Glycine betaine/carnitine/choline-binding protein	0	0	1	1
Chain A, Choline-binding protein	0	0	1	1
Solute carrier family 22 member 1	0	3	0	4
Solute carrier family 22 member 2	0	3	0	3
Neuronal acetylcholine receptor subunit alpha-3	0	5	3	9
Neuronal acetylcholine receptor subunit alpha-2	0	3	3	7
Neuronal acetylcholine receptor subunit beta-3	0	3	3	7
Neuronal acetylcholine receptor subunit beta-4	0	5	3	9
Neuronal acetylcholine receptor subunit alpha-5	0	3	3	7
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Choline O-acetyltransferase	0	2	0	3
Neuronal acetylcholine receptor subunit alpha-6	0	4	3	8
Neuronal acetylcholine receptor subunit alpha-9	0	3	3	7
High affinity choline transporter 1	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-10	0	3	3	7
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	3	0	3
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	3	0	3
cGMP-inhibited 3',5'-cyclic phosphodiesterase B	0	4	0	4
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	0	5	0	5
cGMP-inhibited 3',5'-cyclic phosphodiesterase A	0	5	0	5
DNA gyrase subunit B	0	1	0	1
DNA gyrase subunit A	0	1	0	1
DNA gyrase subunit B	0	1	0	2
DNA gyrase subunit A	0	2	0	4
DNA gyrase subunit B	0	2	0	4
DNA topoisomerase 4 subunit A	0	1	0	1
DNA topoisomerase 4 subunit B	0	1	0	2
DNA topoisomerase 4 subunit A	0	1	0	2
DNA topoisomerase 2-alpha	0	1	0	4
DNA gyrase subunit A	0	1	0	2
Multidrug resistance protein MdtK	0	0	1	1
DNA gyrase subunit B	0	2	0	2
DNA gyrase subunit A	0	2	0	2
Enoyl-[acyl-carrier-protein] reductase [NADH]	0	1	0	4
DNA topoisomerase 4 subunit A	0	1	0	1
DNA topoisomerase 4 subunit B	0	1	0	1
Integrase	0	1	0	1
3-hydroxy-3-methylglutaryl-coenzyme A reductase	0	2	0	2
Beta-2 adrenergic receptor	0	11	1	12
Beta-3 adrenergic receptor	0	6	1	7
Dipeptidyl peptidase 4	0	2	0	2
Insulin receptor	0	2	0	2
5-hydroxytryptamine receptor 4	0	3	1	4
Neutral alpha-glucosidase AB	0	1	0	1
Heparanase	0	0	3	3
NPC intracellular cholesterol transporter 1 precursor	13	0	0	13
Sodium-dependent noradrenaline transporter	0	3	0	3
Aldo-keto reductase family 1 member B1	0	4	0	4
Aromatase	0	1	0	1
Sodium-dependent serotonin transporter	0	3	0	3
Sodium-dependent dopamine transporter	0	7	0	7
Translocator protein	0	2	0	2
Translocator protein	0	3	0	3
Beta-1 adrenergic receptor	0	2	2	5
Alpha-1B adrenergic receptor	0	0	3	3
Membrane primary amine oxidase	0	1	0	1
Alpha-1A adrenergic receptor	0	2	3	5
Alpha-2B adrenergic receptor	0	1	0	2
Alpha-2C adrenergic receptor	0	1	0	2
Alpha-2A adrenergic receptor	0	1	0	2
Nischarin	0	3	0	3
transient receptor potential cation channel subfamily V member 1	2	0	0	2
Endothelin receptor type B	1	3	0	4
5-hydroxytryptamine receptor 3A	0	5	0	5
Endothelin receptor type B	0	3	0	3
Histamine H1 receptor	0	6	0	6
D(2) dopamine receptor	0	2	0	2
D(2) dopamine receptor	0	3	0	3
5-hydroxytryptamine receptor 2B	0	4	0	4
Transporter	0	5	0	5
Cholecystokinin receptor type A	0	2	0	2
5-hydroxytryptamine receptor 1A	0	2	0	2
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION	0	0	1	1
Chain H, Fab M82G2, Heavy chain	0	0	1	1
Chain L, Fab M82G2, Light chain	0	0	1	1
Chain H, Fab M82g2, Heavy Chain	0	0	1	1
Chain L, Fab M82g2, Light Chain	0	0	1	1
Fatty acid-binding protein, heart	0	1	0	1
Muscarinic acetylcholine receptor M2	0	1	0	1
Lysosomal Pro-X carboxypeptidase	0	2	0	2
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	6	0	7
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	8	0	8
Leukotriene B4 receptor 1	0	1	0	2
Leukotriene B4 receptor 2	0	1	0	2
interleukin 8	7	0	0	7
PAX8	0	0	0	1
nuclear receptor subfamily 0 group B member 1	0	1	0	1
steroidogenic factor 1	0	1	0	1
caspase-1 isoform alpha precursor	3	0	0	3
Tubulin alpha-1A chain	0	2	1	3
Tubulin beta chain	0	2	1	3
Plasma kallikrein	0	0	0	5
Tubulin beta-4A chain	0	2	2	5
Tubulin beta chain	0	2	2	5
Tubulin alpha-3C chain	0	2	2	5
Serine/threonine-protein kinase pim-1	0	1	0	1
Nuclear receptor ROR-gamma	10	1	1	12
Tubulin alpha-1B chain	0	2	2	5
Tubulin alpha-4A chain	0	2	2	5
Tubulin beta-4B chain	0	2	2	5
Vesicular acetylcholine transporter	0	1	0	1
Tubulin beta-3 chain	0	2	2	5
Tubulin beta-2A chain	0	2	2	5
Tubulin polymerization-promoting protein	0	0	1	1
Tubulin beta-8 chain	0	2	2	5
Tubulin beta-2B chain	0	3	0	3
Tubulin alpha-3E chain	0	2	2	5
Tubulin alpha-1A chain	0	2	2	5
Similar to alpha-tubulin isoform 1	0	2	0	2
Similar to alpha-tubulin isoform 1	0	2	0	2
CREB-binding protein	1	1	0	2
Tubulin alpha-1C chain	0	2	2	5
Tubulin beta-6 chain	0	2	2	5
Tubulin beta-2B chain	0	2	2	5
Tubulin beta-1 chain	0	2	2	5
B2 bradykinin receptor	0	1	0	1
Dihydrofolate reductase	0	3	0	5
Dihydrofolate reductase	0	1	0	1
Chymotrypsinogen A	0	2	0	3
Beta-lactamase	0	2	0	2
Beta-lactamase	0	0	0	1
Beta-galactosidase	0	2	0	3
Choline O-acetyltransferase	0	1	0	1
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2	0	2	0	2
PH domain leucine-rich repeat-containing protein phosphatase 2	0	1	0	1
Chymotrypsin-C	0	1	0	1
Sodium- and chloride-dependent creatine transporter 1	0	1	0	1
Phosphodiesterase	0	3	0	3
Multidrug resistance-associated protein 5	0	0	0	1
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
Chain A, N-methyl-D-aspartate Receptor Subunit 1	0	1	0	1
D-alanine--D-alanine ligase	0	1	0	1
UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase	0	1	0	1
Kappa-type opioid receptor	0	11	4	20
Kappa-type opioid receptor	0	14	5	20
Mu-type opioid receptor	0	11	3	21
GTP-binding nuclear protein Ran isoform 1	3	0	0	3
Glutathione S-transferase P	0	1	0	1
Alpha-tocopherol transfer protein	0	0	1	1
Cytochrome P450 2D1	0	2	0	2
Cytochrome P450 2D26	0	2	0	2
Cytochrome P450 2D3	0	2	0	2
Taste receptor type 2 member 46	0	0	1	1
Cytochrome P450 2D4	0	2	0	2
Gamma-aminobutyric acid	0	2	1	3
Fatty acid-binding protein, liver	0	3	0	3
Alpha-1-acid glycoprotein 1	0	0	0	1
Gamma-aminobutyric acid receptor subunit alpha-6	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-2	0	2	1	3
Gamma-aminobutyric acid receptor subunit delta	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-2	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit beta-1	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-1	0	2	1	3
Gamma-aminobutyric acid receptor subunit beta-3	0	2	1	3
Gamma-aminobutyric acid receptor subunit alpha-5	0	2	1	3
Gamma-aminobutyric acid receptor subunit pi	0	2	1	3
Sphingosine-1-phosphate lyase 1	0	2	0	2
Gamma-aminobutyric acid receptor subunit alpha-4	0	2	1	3
Gamma-aminobutyric acid receptor subunit theta	0	2	1	3
Gamma-aminobutyric acid receptor subunit gamma-1	0	2	1	3
Synaptic vesicular amine transporter	0	5	2	7
polyunsaturated fatty acid lipoxygenase ALOX12	3	0	0	3
runt-related transcription factor 1 isoform AML1b	2	0	0	2
core-binding factor subunit beta isoform 2	2	0	0	2
Caspase-7	3	0	0	3
huntingtin isoform 2	10	0	0	10
Histamine N-methyltransferase	0	0	0	1
Calcium release-activated calcium channel protein 1	0	1	0	1
Protein orai-2	0	1	0	1
Protein orai-3	0	1	0	1
Tyrosine-protein kinase Lck	0	4	0	4
cGMP-specific 3',5'-cyclic phosphodiesterase	0	3	0	3
Acetylcholinesterase	0	4	0	4
Amine oxidase [flavin-containing] A	0	8	0	9
Amine oxidase [flavin-containing] A	0	3	0	4
Acetylcholinesterase	0	6	0	6
Acetylcholinesterase	0	5	0	5
Glycogen synthase kinase-3 beta	0	1	0	1
Cholinesterase	0	3	0	3
Acetylcholine receptor subunit epsilon	0	1	2	3
Acyl-CoA:cholesterol acyltransferase	0	2	0	2
Carboxylic ester hydrolase	0	2	0	2
Carboxylic ester hydrolase	0	6	0	6
Mas-related G-protein coupled receptor member X2	0	0	3	3
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta))	0	1	0	1
histone-lysine N-methyltransferase 2A isoform 2 precursor	13	0	0	13
Retinoic acid receptor RXR-alpha	0	3	2	5
Oxoeicosanoid receptor 1	0	1	0	1
Opioid receptor, delta 1b	0	2	0	2
Opioid receptor homologue	0	2	0	2
Proenkephalin-B	0	0	1	1
Mu-type opioid receptor	0	2	0	2
serine-protein kinase ATM isoform a	3	0	0	3
cGMP-dependent 3',5'-cyclic phosphodiesterase	0	3	0	3
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	3	0	3
Endothelin-1 receptor	0	1	0	1
UDP-glucuronosyltransferase 1A9	0	2	0	7
Catechol O-methyltransferase	0	3	0	3
Catechol O-methyltransferase	0	3	0	3
UDP-glucuronosyltransferase 2B15	0	0	0	2
Alpha-ketoglutarate-dependent dioxygenase FTO	0	2	0	2
Chain A, Troponin C, slow skeletal and cardiac muscles	0	0	1	1
Chain A, Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	0	0	1	1
Chain A, POLYMERASE PA	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
Chain A, Polymerase Pa	0	1	0	1
pyruvate kinase PKM isoform a	2	0	0	2
nuclear factor NF-kappa-B p105 subunit isoform 1	3	0	1	4
Prostaglandin E synthase	0	2	0	2
Polycomb protein EED	0	0	1	1
NAD kinase	0	2	1	3
Urokinase-type plasminogen activator	0	1	0	1
Tissue-type plasminogen activator	0	1	0	1
Transthyretin	0	1	3	4
Polymerase acidic protein	0	1	1	2
Plasminogen activator inhibitor 1	0	1	0	1
Heme oxygenase 1	0	1	0	1
Urokinase-type plasminogen activator	0	1	0	1
Heat shock protein HSP 90-beta	0	1	0	1
Neutrophil elastase	0	3	0	3
72 kDa type IV collagenase	0	1	0	1
Hepatocyte growth factor receptor	0	2	0	2
Matrilysin	0	2	0	2
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI	0	1	0	1
Alpha-amylase 1A	0	1	0	1
Apoptosis regulator Bcl-2	0	2	0	2
Microtubule-associated protein tau	0	2	1	3
Glucose-6-phosphate 1-dehydrogenase	0	1	0	1
Fatty acid synthase	0	1	0	1
CPG DNA methylase	0	1	0	1
Lethal factor	0	2	0	2
Phosphoglycerate mutase 1	0	1	0	1
Heme oxygenase 2	0	1	0	1
DNA (cytosine-5)-methyltransferase 1	0	2	0	2
Signal transducer and activator of transcription 1-alpha/beta	0	0	1	1
DNA repair protein RAD52 homolog	0	2	0	2
Fatty acid synthase	0	2	0	2
Matrix metalloproteinase-14	0	1	0	1
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6	0	1	0	1
Squalene monooxygenase	0	1	0	1
6-phosphogluconate dehydrogenase, decarboxylating	0	2	0	2
BH3-interacting domain death agonist	0	1	0	1
Lactoperoxidase	0	2	0	3
Bcl-2-like protein 1	0	2	0	2
Induced myeloid leukemia cell differentiation protein Mcl-1	0	1	0	1
Histone acetyltransferase p300	0	1	0	1
Alpha-(1,3)-fucosyltransferase 7	0	1	0	1
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1	0	1	0	1
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1	0	3	1	4
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	1	0	1
Mitogen-activated protein kinase 14	0	2	1	3
Bcl-2-related protein A1	0	1	0	1
Dual specificity tyrosine-phosphorylation-regulated kinase 1A	0	1	0	1
3-oxoacyl-[acyl-carrier-protein] reductase	0	1	0	1
MAP kinase-activated protein kinase 5	0	1	0	1
Histone acetyltransferase KAT2B	0	1	0	1
Bcl-2-like protein 2	0	1	0	1
Bcl2-associated agonist of cell death	0	1	0	1
Histone acetyltransferase KAT5	0	1	0	1
Enoyl-acyl-carrier protein reductase	0	2	0	2
3-oxoacyl-acyl-carrier protein reductase	0	1	0	1
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein)	0	1	0	1
Bcl-2-like protein 10	0	1	0	1
Adenylate cyclase	0	1	0	1
Thromboxane-A synthase	0	3	0	3
Acetylcholine receptor subunit alpha	0	3	1	4
Acetylcholine receptor subunit beta	0	3	1	4
Acetylcholine receptor subunit gamma	0	3	1	4
Acetylcholine receptor subunit delta	0	1	0	1
Acetylcholine receptor subunit delta	0	3	1	4
Acetylcholine receptor subunit alpha	0	1	0	1
Acetylcholine receptor subunit gamma	0	1	0	1
Acetylcholine receptor subunit beta	0	1	0	1
Cytochrome P450 11B1, mitochondrial	0	1	0	1
Cytochrome P450 11B2, mitochondrial	0	1	0	1
Cytochrome P450 1A1	0	0	1	1
5-hydroxytryptamine receptor 2A	0	3	1	4
Chain A, Uracil Phosphoribosyltransferase	0	1	0	1
Skn7p	0	0	0	1
Solute carrier family 22 member 8	0	1	0	2
Thymidylate synthase	0	2	0	2
HSP40, subfamily A [Plasmodium falciparum 3D7]	0	0	0	1
Potassium voltage-gated channel subfamily C member 1	0	1	0	1
Gastrin/cholecystokinin type B receptor	0	1	0	1
eyes absent homolog 2 isoform a	2	0	0	2
tumor susceptibility gene 101 protein	1	0	0	1
Potassium voltage-gated channel subfamily KQT member 3	0	0	1	2
Potassium voltage-gated channel subfamily KQT member 2	0	0	1	2
Serine hydroxymethyltransferase, mitochondrial	0	1	0	1
Potassium voltage-gated channel subfamily KQT member 4	0	0	0	1
Potassium voltage-gated channel subfamily KQT member 5	0	0	0	1
Cytochrome P450 1A2	0	1	0	1
Chain A, Dihydrofolate reductase	0	0	1	1
acid sphingomyelinase	1	0	0	1
Thymidylate synthase	0	2	0	2
Dihydrofolate reductase	0	2	1	3
Aldo-keto reductase family 1 member B1	0	3	0	3
Folylpolyglutamate synthase, mitochondrial	0	0	0	1
Solute carrier organic anion transporter family member 1A3	0	2	0	2
Folylpolyglutamate synthase, mitochondrial	0	0	0	1
Multidrug resistance associated protein	0	0	0	1
Menin	0	0	1	1
Lecithin retinol acyltransferase	0	1	0	1
30S ribosomal protein S6	0	1	0	1
30S ribosomal protein S7	0	1	0	1
50S ribosomal protein L15	0	1	0	1
50S ribosomal protein L10	0	1	0	1
50S ribosomal protein L11	0	1	0	1
50S ribosomal protein L7/L12	0	1	0	1
50S ribosomal protein L19	0	1	0	1
50S ribosomal protein L1	0	1	0	1
50S ribosomal protein L20	0	1	0	1
50S ribosomal protein L27	0	1	0	1
50S ribosomal protein L28	0	1	0	1
50S ribosomal protein L29	0	1	0	1
50S ribosomal protein L31	0	1	0	1
50S ribosomal protein L31 type B	0	1	0	1
50S ribosomal protein L32	0	1	0	1
50S ribosomal protein L33	0	1	0	1
50S ribosomal protein L34	0	1	0	1
50S ribosomal protein L35	0	1	0	1
50S ribosomal protein L36	0	1	0	1
30S ribosomal protein S10	0	1	0	1
30S ribosomal protein S11	0	1	0	1
30S ribosomal protein S12	0	1	0	1
30S ribosomal protein S13	0	1	0	1
30S ribosomal protein S16	0	1	0	1
30S ribosomal protein S18	0	1	0	1
30S ribosomal protein S19	0	1	0	1
30S ribosomal protein S20	0	1	0	1
30S ribosomal protein S2	0	1	0	1
30S ribosomal protein S3	0	1	0	1
30S ribosomal protein S4	0	1	0	1
30S ribosomal protein S5	0	1	0	1
30S ribosomal protein S8	0	1	0	1
30S ribosomal protein S9	0	1	0	1
50S ribosomal protein L13	0	1	0	1
50S ribosomal protein L14	0	1	0	1
50S ribosomal protein L16	0	1	0	1
50S ribosomal protein L23	0	1	0	1
30S ribosomal protein S15	0	1	0	1
50S ribosomal protein L17	0	1	0	1
50S ribosomal protein L21	0	1	0	1
50S ribosomal protein L30	0	1	0	1
50S ribosomal protein L6	0	1	0	1
30S ribosomal protein S14	0	1	0	1
30S ribosomal protein S17	0	1	0	1
30S ribosomal protein S1	0	1	0	1
50S ribosomal protein L18	0	1	0	1
50S ribosomal protein L2	0	1	0	1
50S ribosomal protein L3	0	1	0	1
50S ribosomal protein L24	0	1	0	1
50S ribosomal protein L4	0	1	0	1
50S ribosomal protein L22	0	1	0	1
50S ribosomal protein L5	0	1	0	1
30S ribosomal protein S21	0	1	0	1
50S ribosomal protein L25	0	1	0	1
50S ribosomal protein L36 2	0	1	0	1
Protein Rev	0	0	1	1
Aminoglycoside 3'-phosphotransferase	0	0	0	1
Tyrosyl-DNA phosphodiesterase 1	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	2	0	2
Lipopolysaccharide heptosyltransferase 1	0	1	0	1
PA-I galactophilic lectin	0	0	1	1
Jacalin	0	0	1	1
Chain A, Beta-phosphoglucomutase	0	1	0	1
Chain A, Beta-phosphoglucomutase	0	1	0	1
Chain A, ACETYLCHOLINESTERASE	0	1	0	1
Chain A, Acetylcholinesterase	0	1	0	1
Vascular endothelial growth factor receptor 1	0	1	0	1
Vascular endothelial growth factor receptor 3	0	1	0	1
Vascular endothelial growth factor receptor 2	0	1	0	1
Small conductance calcium-activated potassium channel protein 3	0	1	0	1
Gamma-aminobutyric acid receptor subunit rho-3	0	0	1	1
Hsf1 protein	0	0	2	3
Sodium- and chloride-dependent GABA transporter 1	0	4	0	4
Gamma-aminobutyric acid receptor subunit rho-1	0	0	4	4
Gamma-aminobutyric acid receptor subunit rho-2	0	0	2	2
Sodium- and chloride-dependent GABA transporter 1	0	1	0	1
Sodium- and chloride-dependent taurine transporter	0	1	0	1
Sodium- and chloride-dependent GABA transporter 2	0	4	0	4
Sodium- and chloride-dependent GABA transporter 3	0	4	0	4
Sodium- and chloride-dependent GABA transporter 1	0	1	0	1
Sodium- and chloride-dependent GABA transporter 2	0	2	0	2
Sodium- and chloride-dependent GABA transporter 3	0	2	0	2
Sodium- and chloride-dependent betaine transporter	0	4	0	4
Sodium- and chloride-dependent betaine transporter	0	1	0	1
Sodium- and chloride-dependent GABA transporter 3	0	1	0	1
4-aminobutyrate aminotransferase, mitochondrial	0	0	0	1
4-aminobutyrate aminotransferase, mitochondrial	0	0	0	1
Sterol O-acyltransferase 1	0	0	1	1
Platelet glycoprotein VI	0	0	1	1
Sodium- and chloride-dependent GABA transporter 2	0	1	0	1
Glucagon-like peptide 1 receptor	0	0	1	1
Glucagon-like peptide 1 receptor	0	1	1	2
Glucagon receptor	0	0	1	1
Glucagon receptor	0	0	1	1
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2	0	1	0	1
Chain A, Glutamate Receptor Subunit 2	0	1	0	1
Chain B, Glutamate Receptor Subunit 2	0	1	0	1
Chain A, Slr1257 protein	0	0	1	1
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing]	0	1	0	1
beta-2 adrenergic receptor	3	0	0	3
Metabotropic glutamate receptor 8	0	2	0	2
Glutathione reductase, mitochondrial	0	5	0	6
Bifunctional aspartokinase/homoserine dehydrogenase 1	0	1	0	1
ATP-citrate synthase	0	1	0	1
Glutamate receptor ionotropic, kainate 1	0	4	1	5
Metabotropic glutamate receptor 1	0	1	2	3
Metabotropic glutamate receptor 2	0	0	1	1
Metabotropic glutamate receptor 3	0	0	1	1
Metabotropic glutamate receptor 4	0	1	1	2
Metabotropic glutamate receptor 5	0	2	1	3
Metabotropic glutamate receptor 6	0	0	1	1
Metabotropic glutamate receptor 7	0	0	1	1
Glutamate receptor ionotropic, kainate 1	0	1	1	2
Metabotropic glutamate receptor 5	0	4	2	7
Glutamate receptor ionotropic, kainate 2	0	4	1	5
Glutamate receptor 1	0	3	1	4
Glutamate receptor 2	0	2	1	3
Glutamate receptor 3	0	1	1	2
Metabotropic glutamate receptor 8	0	0	1	1
Glutamate receptor 4	0	2	1	3
Excitatory amino acid transporter 3	0	0	0	1
Glutamate racemase	0	0	0	1
Metabotropic glutamate receptor 8	0	1	1	2
Glutamate receptor ionotropic, kainate 4	0	4	0	4
Glutamate carboxypeptidase 2	0	1	0	1
Glutamate receptor ionotropic, kainate 2	0	1	1	2
Glutamate receptor ionotropic, kainate 3	0	1	0	1
Metabotropic glutamate receptor 7	0	1	1	3
Metabotropic glutamate receptor 3	0	1	1	3
Metabotropic glutamate receptor 4	0	2	2	5
Glutamate receptor ionotropic, kainate 5	0	1	0	1
Glutamate receptor ionotropic, kainate 5	0	4	0	4
Glutamate racemase	0	0	0	1
Prolyl 4-hydroxylase	0	1	0	1
Chain A, Glutamine Binding Protein	0	0	1	1
Neutral amino acid transporter A	0	3	0	3
Asc-type amino acid transporter 1	0	1	0	1
Neutral amino acid transporter B(0)	0	3	0	3
Amino acid transporter	0	3	0	3
Chain A, Protein (aspartate Aminotransferase)	0	0	1	1
Chain A, Aspartate Aminotransferase	0	0	1	1
Solute carrier family 22 member 20	0	3	0	3
Solute carrier family 22 member 6	0	3	0	3
Solute carrier family 22 member 7	0	0	0	1
ATP-binding cassette sub-family C member 9	0	1	0	1
Solute carrier organic anion transporter family member 2B1	0	2	0	3
ATP synthase subunit beta, mitochondrial	0	1	0	1
ATP synthase subunit delta, mitochondrial	0	1	0	1
ATP synthase subunit gamma, mitochondrial	0	1	0	1
ATP synthase subunit epsilon, mitochondrial	0	1	0	1
Cystic fibrosis transmembrane conductance regulator	0	1	0	1
Cholesteryl ester transfer protein	0	1	0	1
Malate dehydrogenase, cytoplasmic	0	1	0	1
Solute carrier family 15 member 1	0	2	0	2
ATP-binding cassette sub-family C member 8	0	1	0	1
ATP-sensitive inward rectifier potassium channel 11	0	1	0	1
Solute carrier family 22 member 7	0	2	0	4
Solute carrier family 15 member 2	0	2	0	2
NACHT, LRR and PYD domains-containing protein 3	0	1	0	1
NACHT, LRR and PYD domains-containing protein 3	0	1	0	1
CDGSH iron-sulfur domain-containing protein 1	0	2	0	2
Solute carrier organic anion transporter family member 1B1	0	5	0	5
Glycine receptor subunit alpha-1	0	0	3	3
Sodium- and chloride-dependent glycine transporter 1	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	9	0	10
Serine racemase	0	1	0	1
Olfactory receptor 51E2	0	0	2	2
Sodium- and chloride-dependent glycine transporter 2	0	1	0	1
Chain A, Probable hydrogenase nickel incorporation protein hypB	0	0	1	1
Chain B, Probable hydrogenase nickel incorporation protein hypB	0	0	1	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	6	0	6
Vitamin D-binding protein	0	1	0	1
HLA class I histocompatibility antigen, A alpha chain	0	0	1	1
Integrin beta-1	0	1	0	1
Integrin alpha-4	0	1	0	1
Carbonyl reductase [NADPH] 1	0	0	0	1
C-8 sterol isomerase	0	2	0	2
AP-2 complex subunit sigma	0	1	0	1
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase	0	2	0	2
Calcitonin gene-related peptide type 1 receptor	0	1	0	1
Genome polyprotein	0	2	0	2
Zinc finger protein 664	0	1	0	1
Vesicular acetylcholine transporter	0	1	0	1
Protease	0	5	0	5
Mitogen-activated protein kinase 10	0	1	2	3
Neuraminidase	0	3	0	3
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1	0	1	0	1
3-oxo-5-alpha-steroid 4-dehydrogenase 1	0	2	0	2
Substance-P receptor	0	4	0	4
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	2	0	2
Substance-K receptor	0	1	0	1
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1	0	1	0	1
ClpP	3	0	0	3
Solute carrier family 22 member 8	0	2	0	3
pyruvate kinase	4	0	0	4
pyruvate kinase PKM isoform b	3	0	0	3
N-glycosylase/DNA lyase	0	2	0	2
Myeloperoxidase	0	5	0	5
Ornithine decarboxylase	3	0	0	4
Aspartate aminotransferase, cytoplasmic	0	1	0	1
Uracil nucleotide/cysteinyl leukotriene receptor	0	3	0	3
Nrf2	1	0	0	1
Chain A, membrane-associated prostaglandin E synthase-2	0	1	0	1
Prostaglandin-H2 D-isomerase	0	1	0	1
Prostaglandin G/H synthase 2	0	1	0	2
3',5'-cyclic-AMP phosphodiesterase	0	1	0	1
Cytochrome c oxidase subunit 2	0	1	0	1
Phospholipase A2, major isoenzyme	0	1	0	1
Interleukin-8	0	1	0	1
Androgen receptor	0	2	1	3
Polyunsaturated fatty acid 5-lipoxygenase	0	2	0	3
Aldo-keto reductase family 1 member C4	0	1	0	1
Prostaglandin G/H synthase 1	0	1	0	1
Indoleamine 2,3-dioxygenase 1	0	3	0	3
Prostaglandin E2 receptor EP3 subtype	0	1	0	1
Prostaglandin E2 receptor EP4 subtype	0	1	0	1
Multidrug resistance-associated protein 1	0	2	0	2
Bifunctional epoxide hydrolase 2	0	1	0	1
Prostaglandin G/H synthase 2	0	2	0	2
Prostaglandin E2 receptor EP1 subtype	0	1	0	1
C-X-C chemokine receptor type 3	0	3	0	3
Prostaglandin D2 receptor	0	2	0	2
Lactoylglutathione lyase	0	1	0	1
Aldo-keto reductase family 1 member C1	0	1	0	1
Prostaglandin G/H synthase 2	0	1	0	2
Prostaglandin E2 receptor EP2 subtype	0	1	0	1
Rho-associated protein kinase 2	0	2	0	2
Prostaglandin G/H synthase 1	0	2	0	2
Nicotinate phosphoribosyltransferase	0	2	0	2
Dehydrogenase/reductase SDR family member 9	0	1	0	1
P2Y purinoceptor 12	0	1	0	1
Solute carrier organic anion transporter family member 1B3	0	2	0	2
Cytosolic phospholipase A2 gamma	0	1	0	1
Prostaglandin D2 receptor 2	0	1	1	2
3-oxoacyl-[acyl-carrier-protein] synthase 3	0	1	0	1
Formamidopyrimidine-DNA glycosylase	0	1	0	1
Macrophage migration inhibitory factor	0	1	0	1
Endonuclease III-like protein 1	0	1	0	1
Pantothenate synthetase	0	1	0	1
Isocitrate lyase	0	1	0	1
Putative FAD-containing monooxygenase MymA	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Endonuclease 8-like 1	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1D	0	2	0	2
3-oxoacyl-[acyl-carrier-protein] synthase 3	0	1	0	1
Gap junction alpha-1 protein	0	1	0	1
Gap junction beta-2 protein	0	1	0	1
Acyl-protein thioesterase 1	0	1	0	1
5-hydroxytryptamine receptor 1E	0	3	0	3
Potassium voltage-gated channel subfamily E member 1	0	2	0	2
Potassium voltage-gated channel subfamily KQT member 1	0	3	0	3
Sodium channel protein type 10 subunit alpha	0	1	0	1
Chain A, AMINOPEPTIDASE	0	2	0	2
Chain A, AMINOPEPTIDASE	0	2	0	2
Chain A, Leucine Aminopeptidase	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	5	0	5
Intestinal-type alkaline phosphatase	0	4	0	4
Phospholipase A-2-activating protein	0	4	0	4
chaperonin-containing TCP-1 beta subunit homolog	3	0	0	3
Synaptic vesicle glycoprotein 2A	0	2	0	2
integrase, partial	0	2	0	2
lens epithelium-derived growth factor p75	0	2	0	2
Solute carrier family 15 member 1	0	1	0	1
SLC16A10 protein	0	0	0	4
Monocarboxylate transporter 10	0	0	0	4
Potassium voltage-gated channel subfamily A member 5	0	2	0	2
Potassium voltage-gated channel subfamily D member 2	0	1	0	1
Potassium channel subfamily K member 18	0	1	0	1
Dipeptidyl peptidase 9	0	1	0	1
Dipeptidyl peptidase IV	0	1	0	1
Prolyl endopeptidase FAP	0	1	0	1
Prolyl endopeptidase FAP	0	1	0	1
Dipeptidyl peptidase 8	0	1	0	1
Dipeptidyl peptidase 9	0	1	0	1
Dipeptidyl peptidase 2	0	1	0	1
Chain A, Antigen Cd11a (p180)	0	1	0	1
PINK1	1	0	0	1
isocitrate dehydrogenase 1, partial	2	0	0	2
thyrotropin-releasing hormone receptor	2	0	0	2
bcl-2-related protein A1	0	3	0	3
Integrin beta-2	0	1	0	1
Intercellular adhesion molecule 1	0	1	0	1
Integrin alpha-L	0	1	1	2
Rap guanine nucleotide exchange factor 4	6	0	0	6
Cysteinyl leukotriene receptor 1	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Synaptic vesicular amine transporter	0	4	1	5
Trace amine-associated receptor 1	0	0	1	1
Trace amine-associated receptor 1	0	0	2	2
Trace amine-associated receptor 1	0	0	2	2
Trace amine-associated receptor 1	0	0	2	2
Dopamine beta-hydroxylase	0	2	0	2
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Methionyl-tRNA synthetase	0	0	1	1
Chain A, Aminopeptidase	0	1	0	1
Chain A, Methionine aminopeptidase	0	1	0	1
S-ribosylhomocysteine lyase	0	1	0	1
Adenylate cyclase type 5	0	1	0	2
S-adenosylmethionine synthase isoform type-1	0	0	0	1
S-adenosylmethionine synthase isoform type-2	0	0	0	1
Chain E, Fibrin beta chain	0	1	0	1
T cell receptor, partial	1	0	0	1
luteinizing hormone receptor	1	0	0	1
Caspase 6, apoptosis-related cysteine peptidase	0	0	0	1
TSHR protein	1	0	0	1
Apoptotic peptidase activating factor 1	0	1	0	1
luciferase	1	0	0	1
neutrophil cytosol factor 1	0	2	0	2
caspase-9 isoform alpha precursor	0	1	0	1
caspase-3 isoform a preproprotein	0	1	0	1
protein AF-9 isoform a	0	0	0	1
replicative DNA helicase	0	0	0	1
recombinase A	0	0	1	1
DNA repair protein RAD52 homolog isoform a	0	0	0	2
Glutathione reductase	0	1	0	1
Glycoprotein hormones alpha chain	2	0	0	2
Dihydrolipoyl dehydrogenase, mitochondrial	0	1	0	2
Cruzipain	0	1	0	1
Thioredoxin reductase 1, cytoplasmic	0	1	0	2
Dihydrolipoyl dehydrogenase	0	1	0	2
Glucocorticoid receptor	0	6	2	13
Glycine receptor subunit alpha-1	0	6	0	6
Glycine receptor subunit beta	0	6	0	6
Glycine receptor subunit alpha-2	0	6	0	6
Glycine receptor subunit alpha-3	0	6	0	6
Nuclear receptor subfamily 1 group I member 2	0	0	1	1
5-hydroxytryptamine receptor 3B	0	3	0	3
Thioredoxin reductase	0	1	0	1
Flavodoxin	0	0	0	2
Endothelin-1 receptor	0	2	1	3
Type-2 angiotensin II receptor	0	3	0	3
Angiotensin-converting enzyme	0	2	0	2
G-protein coupled receptor	0	1	0	1
Stromelysin-1	0	2	1	3
Multidrug transporter MdfA	0	1	0	1
Matrix metalloproteinase-9	0	1	0	1
Protein mono-ADP-ribosyltransferase PARP15	0	1	0	1
Protein-arginine deiminase type-4	0	2	0	2
Acyl-CoA desaturase 1	0	2	0	2
Histidine decarboxylase	0	0	3	3
Proteinase-activated receptor 1	0	1	1	2
UDP-glucuronosyltransferase 1A3	0	0	0	1
Nociceptin receptor	0	1	0	1
Mu-type opioid receptor	0	1	0	1
D-amino-acid oxidase	0	1	0	1
5-hydroxytryptamine receptor 1B	0	1	0	1
Sialidase-4	0	2	0	2
Sialidase-1	0	2	0	2
Sialidase-3	0	2	0	2
Sialidase-2	0	2	0	2
UDP-glucuronosyltransferase 1A8	0	0	0	3
Nociceptin receptor	0	2	1	3
ubiquitin-conjugating enzyme E2 N	0	2	0	2
G protein-activated inward rectifier potassium channel 2	0	0	1	1
G protein-activated inward rectifier potassium channel 4	0	0	1	1
G protein-activated inward rectifier potassium channel 1	0	0	1	1
Neuronal acetylcholine receptor subunit alpha-4	0	2	1	3
Transient receptor potential cation channel subfamily A member 1	0	1	3	4
Neuronal acetylcholine receptor subunit alpha-4	0	1	0	1
Acetylcholine receptor subunit beta-like 2	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-5	0	0	1	1
Neuronal acetylcholine receptor subunit alpha-7	0	2	0	2
Acetylcholine-binding protein	0	1	1	2
Neuronal acetylcholine receptor subunit beta-3	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-6	0	1	1	2
Cytochrome P450 2A13	0	1	1	2
Neuronal acetylcholine receptor subunit alpha-5	0	2	0	2
Liver carboxylesterase B-1	0	1	0	1
Transient receptor potential cation channel subfamily A member 1	0	0	3	3
Neuronal acetylcholine receptor subunit beta-3	0	2	0	2
Neuronal acetylcholine receptor subunit beta-4	0	2	0	2
Neuronal acetylcholine receptor subunit alpha-3	0	2	0	2
Soluble acetylcholine receptor	0	1	0	1
Neuronal acetylcholine receptor subunit alpha-2	0	2	0	2
Neuronal acetylcholine receptor subunit beta-2	0	2	1	3
Neuronal acetylcholine receptor subunit alpha-6	0	2	0	2
Integrin beta	0	0	1	1
Glycoprotein IIb	0	0	1	1
tumor necrosis factor	1	0	0	1
perilipin-5	0	1	0	1
perilipin-1	0	1	0	1
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a	0	1	0	1
Phospholipase A2, membrane associated	0	0	0	1
Voltage-dependent L-type calcium channel subunit alpha-1C	0	3	0	3
Platelet-activating factor receptor	0	0	0	1
C-C chemokine receptor type 2	0	2	0	2
Voltage-dependent L-type calcium channel subunit alpha-1C	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1S	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1S	0	1	0	1
C-terminal-binding protein 1	1	0	0	1
Myosin light chain kinase, smooth muscle	0	1	0	1
Indoleamine 2,3-dioxygenase 2	0	2	0	2
Voltage-dependent L-type calcium channel subunit alpha-1D	0	1	0	1
Voltage-dependent L-type calcium channel subunit alpha-1F	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-4	0	1	0	1
Voltage-dependent P/Q-type calcium channel subunit alpha-1A	0	1	0	1
Voltage-dependent T-type calcium channel subunit alpha-1G	0	1	1	2
Voltage-dependent calcium channel gamma-3 subunit	0	1	0	1
Voltage-dependent T-type calcium channel subunit alpha-1H	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-3	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-1	0	1	0	1
Voltage-dependent calcium channel gamma-7 subunit	0	1	0	1
Voltage-dependent N-type calcium channel subunit alpha-1B	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-1	0	1	0	1
Voltage-dependent calcium channel gamma-1 subunit	0	1	0	1
Voltage-dependent L-type calcium channel subunit beta-2	0	1	0	1
Voltage-dependent R-type calcium channel subunit alpha-1E	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-4	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-3	0	1	0	1
Voltage-dependent calcium channel gamma-8 subunit	0	1	0	1
Bile acid receptor	0	1	0	1
Voltage-dependent calcium channel gamma-6 subunit	0	1	0	1
Voltage-dependent calcium channel subunit alpha-2/delta-2	0	1	0	1
Voltage-dependent T-type calcium channel subunit alpha-1I	0	1	0	1
Voltage-dependent calcium channel gamma-4 subunit	0	1	0	1
Voltage-dependent calcium channel gamma-5 subunit	0	1	0	1
Voltage-dependent calcium channel gamma-2 subunit	0	1	0	1
Corticotropin-releasing factor receptor 1	0	0	0	1
Mitogen-activated protein kinase 8	0	0	2	2
Mitogen-activated protein kinase 9	0	0	2	2
kelch-like ECH-associated protein 1	0	0	0	1
Calcium-activated potassium channel subunit alpha-1	0	1	0	2
Calcium-activated potassium channel subunit beta-1	0	0	0	1
FAD-linked sulfhydryl oxidase ALR	0	0	0	2
Glucose-6-phosphate 1-dehydrogenase	0	1	0	1
Catechol O-methyltransferase	0	1	0	1
Neuraminidase	0	2	0	2
Neuraminidase	0	2	0	2
Neuraminidase	0	2	0	2
Sialidase	0	1	0	1
Acyl-CoA desaturase 1	0	1	0	1
Neuraminidase	0	2	0	2
Neuraminidase	0	2	0	2
Neuraminidase	0	1	0	1
Neuraminidase	0	1	0	1
polyadenylate-binding protein 1	0	1	0	1
MBT domain-containing protein 1	0	1	0	1
Lethal(3)malignant brain tumor-like protein 4	0	1	0	1
Lethal(3)malignant brain tumor-like protein 3	0	1	0	1
Lethal(3)malignant brain tumor-like protein 1	0	1	0	1
Vasopressin V2 receptor	0	1	1	2
Oxytocin receptor	0	2	2	4
Vasopressin V1a receptor	0	1	0	1
Vasopressin V1a receptor	0	3	2	5
Vasopressin V1b receptor	0	1	1	2
Vasopressin V1b receptor	0	1	0	1
Oxytocin receptor	0	1	0	1
Oxytocin receptor	0	0	1	1
Vasopressin V2 receptor	0	1	0	1
Type II pantothenate kinase	0	0	0	1
Type III pantothenate kinase	0	0	0	1
Muscarinic acetylcholine receptor DM1	0	2	0	2
Xaa-Pro dipeptidase	0	0	0	1
Quinolone resistance protein NorA	0	2	0	3
Beta-adrenergic receptor kinase 1	0	1	0	1
Beta-adrenergic receptor kinase 1	0	1	1	2
Substance-P receptor	0	3	1	4
Rhodopsin kinase GRK1	0	1	0	1
G protein-coupled receptor kinase 5	0	1	0	1
G protein-coupled receptor kinase 5	0	1	0	1
P2X purinoceptor 4	0	1	0	1
Envelope glycoprotein	0	0	2	2
Rhodopsin kinase GRK1	0	1	0	1
Beta-adrenergic receptor kinase 1	0	0	0	1
vasopressin V1b receptor	1	0	0	1
relaxin receptor 1 isoform 1	1	0	0	1
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A	0	1	0	1
Tumor necrosis factor	0	1	0	1
Chain A, Immunoglobulin	0	0	1	1
Chain B, Immunoglobulin	0	0	1	1
Muscarinic acetylcholine receptor M5	0	1	1	3
Muscarinic acetylcholine receptor M3	0	1	1	3
Muscarinic acetylcholine receptor M2	0	1	1	3
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Chain A, TRYPSIN	0	1	0	1
Membrane primary amine oxidase	0	0	0	1
Cationic trypsin	0	1	0	1
Membrane primary amine oxidase	0	0	0	1
Lysyl oxidase homolog 2	0	1	0	1
Chain A, Lysozyme	0	0	1	1
Chain A, Lysozyme	0	0	1	1
Chain A, Lysozyme	0	0	1	1
Chain A, Lysozyme	0	0	1	1
Chain A, Ferritin light chain	0	0	2	2
Chain A, Ferritin light chain	0	0	2	2
Chain A, Ferritin light chain	0	0	2	2
Chain A, Ferritin light chain	0	0	2	2
Chain A, Ferritin light chain	0	0	2	2
Chain A, Ferritin light chain	0	0	2	2
Chain A, Ferritin light chain	0	0	2	2
Endolysin	0	0	1	1
Sulfotransferase 1A1	0	0	0	1
rac GTPase-activating protein 1 isoform a	0	1	0	1
Gag-Pol polyprotein	0	1	0	1
Gag-Pol polyprotein	0	1	0	1
Alkaline phosphatase, tissue-nonspecific isozyme	0	1	0	1
Intestinal-type alkaline phosphatase	0	1	0	1
5'-nucleotidase	0	1	0	1
E3 ubiquitin-protein ligase XIAP	0	1	0	1
Large neutral amino acids transporter small subunit 1	0	1	0	1
Dihydrofolate reductase	0	1	0	1
Complement C1s subcomponent	0	1	0	1
Collagenase 3	0	1	0	1
Nitric oxide synthase, inducible	0	1	0	1
DNA polymerase III, partial	2	0	0	2
XBP1	0	1	0	1
DNA damage-inducible transcript 3 protein	0	1	0	1
Ubiquitin carboxyl-terminal hydrolase 1	0	2	0	2
WD repeat-containing protein 48	0	2	0	2
luciferase	0	0	0	1
Estrogen receptor	0	3	0	3
Progesterone receptor	0	2	0	3
Glucocorticoid receptor	0	1	1	2
Glucocorticoid receptor	0	0	1	1
Corticosteroid-binding globulin	0	1	0	1
Mineralocorticoid receptor	0	2	1	3
Glutamine synthetase	0	0	1	1
Nociceptin receptor	0	0	1	1
Estrogen receptor beta	0	2	0	2
Solute carrier organic anion transporter family member 1A4	0	2	0	2
Solute carrier organic anion transporter family member 1A1	0	2	0	2
Canalicular multispecific organic anion transporter 1	0	1	0	1
Pannexin-1	0	1	0	1
Solute carrier family 22 member 12	0	1	0	1
Solute carrier organic anion transporter family member 1C1	0	1	0	1
UDP-glucuronosyltransferase 1A7	0	1	0	1
UDP-glucuronosyltransferase 1A10	0	1	0	1
Pannexin-1	0	1	0	1
Solute carrier family 22 member 11	0	2	0	2
Solute carrier family 22 member 7	0	2	0	2
Sterol O-acyltransferase 1	0	1	0	1
Sterol O-acyltransferase 1	0	1	0	1
Solute carrier family 22 member 4	0	1	0	1
DNA (cytosine-5)-methyltransferase 3-like	0	1	0	1
DNA (cytosine-5)-methyltransferase 3A	0	1	0	1
Mcl-1	0	1	0	1
Glutamate 5-kinase	0	0	0	1
Neuromedin-K receptor	0	0	1	1
Type-1 angiotensin II receptor	0	1	1	2
Cholecystokinin receptor type A	0	1	1	2
Beta-1 adrenergic receptor	0	1	0	1
Sodium/bile acid cotransporter	0	1	0	1
Nuclear receptor subfamily 2 group E member 1	0	0	2	2
NAD-dependent protein deacetylase sirtuin-6	0	1	0	1
Pyridoxal kinase	0	0	0	1
Histidine-rich protein PFHRP-II	0	1	0	1
interferon gamma precursor	0	0	0	1
Dipeptidyl peptidase 4	0	0	1	1
DNA topoisomerase 1	0	2	0	2
Chromaffin granule amine transporter	0	1	0	1
Synaptic vesicular amine transporter	0	2	0	2
Chain A, Troponin C, slow skeletal and cardiac muscles	0	0	1	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
Chain A, Leukotriene A-4 hydrolase	0	1	0	1
BRCA1	1	0	0	1
P53	1	0	0	1
M18 aspartyl aminopeptidase	0	1	0	1
cathepsin L1	0	1	0	1
transcription factor p65 isoform 1	0	0	1	1
serine/threonine-protein kinase 33 isoform a	0	0	1	1
Aryl hydrocarbon receptor	0	1	0	1
Estrogen receptor beta	0	1	1	3
Tyrosine-protein kinase ABL1	0	1	0	2
Myc proto-oncogene protein	0	1	0	2
Cathepsin D	0	1	0	1
Luciferin 4-monooxygenase	0	1	0	1
DNA polymerase alpha catalytic subunit	0	1	0	1
Leukotriene A-4 hydrolase	0	1	0	1
Breakpoint cluster region protein	0	1	0	2
Tyrosinase	0	3	0	3
Ornithine decarboxylase	0	1	0	1
Ribosyldihydronicotinamide dehydrogenase [quinone]	0	2	1	3
Estrogen receptor	0	1	1	3
Endothelin-1 receptor	1	0	0	1
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1	0	1	0	1
Alpha-glucosidase MAL12	0	1	0	1
Serine/threonine-protein kinase PAK 1	0	1	0	1
Nuclear factor erythroid 2-related factor 2	0	0	1	2
N1L	0	1	0	1
NAD(P)H dehydrogenase [quinone] 1	0	0	0	3
Lysosomal alpha-glucosidase	0	2	0	2
NAD-dependent protein deacetylase sirtuin-2	0	0	1	1
NAD-dependent protein deacetylase sirtuin-1	0	0	1	3
Prenyltransferase homolog	0	0	0	1
NAD-dependent protein deacetylase sirtuin-3, mitochondrial	0	0	1	1
large T antigen	0	1	0	1
Diacylglycerol kinase alpha	0	1	0	1
Acetylcholine receptor subunit epsilon	0	1	0	1
Cholinesterase	0	1	0	1
Tyrosine-protein kinase SYK	0	1	0	1
NADH-ubiquinone oxidoreductase chain 1	0	1	0	1
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial	0	1	0	1
Dihydroorotate dehydrogenase (fumarate)	0	1	0	1
Acyl carrier protein, mitochondrial	0	1	0	1
Dihydroorotate dehydrogenase	0	1	0	1
Met repressor	0	0	2	2
Protein arginine N-methyltransferase 5	0	0	1	1
Histone H3K27 methylase	0	0	0	1
Phenylethanolamine N-methyltransferase	0	0	1	2
S-adenosylmethionine decarboxylase proenzyme	0	1	0	2
Protein-L-isoaspartate(D-aspartate) O-methyltransferase	0	1	0	1
Catechol O-methyltransferase	0	0	0	1
Protein arginine N-methyltransferase 1	0	2	0	2
Methylosome protein 50	0	0	1	1
Taste receptor type 2 member 31	0	0	1	1
RmtA	0	1	0	1
Renin	0	1	0	1
Inhibitor of nuclear factor kappa-B kinase subunit beta	0	0	0	1
5'-AMP-activated protein kinase subunit beta-2	0	0	0	1
Tyrosine-protein phosphatase YopH	0	1	0	1
High mobility group protein B1	0	0	1	1
Cystathionine gamma-lyase	0	1	0	1
5'-AMP-activated protein kinase subunit gamma-1	0	0	0	1
5'-AMP-activated protein kinase catalytic subunit alpha-2	0	0	0	1
Xanthine dehydrogenase/oxidase	0	1	0	1
5'-AMP-activated protein kinase catalytic subunit alpha-1	0	0	0	1
Ubiquitin-like domain-containing CTD phosphatase 1	0	1	0	1
5'-AMP-activated protein kinase subunit gamma-3	0	0	0	1
5'-AMP-activated protein kinase subunit gamma-2	0	0	0	1
5'-AMP-activated protein kinase subunit beta-1	0	0	0	1
5-hydroxytryptamine receptor 1D	0	1	0	1
Adenylate cyclase type 6	0	1	0	1
Adenylate cyclase type 3	0	1	0	1
Adenylate cyclase type 9	0	1	0	1
D(1) dopamine receptor	0	1	0	1
Adenylate cyclase type 8	0	1	0	1
Adenylate cyclase type 7	0	1	0	1
Adenylate cyclase type 2	0	1	0	1
Adenylate cyclase type 4	0	1	0	1
Cytochrome P450 2B1	0	2	0	2
Type-1 angiotensin II receptor	0	1	0	1
Amine oxidase [flavin-containing] A	0	0	0	1
Pyruvate kinase PKM	0	0	1	1
Transcriptional activator protein LuxR	0	1	0	1
3-oxo-5-alpha-steroid 4-dehydrogenase 2	0	1	0	1
epidermal growth factor receptor isoform a precursor	0	1	0	1
Transcription factor AP-1	0	1	0	1
Mitogen-activated protein kinase 3	0	1	1	2
Dual specificity mitogen-activated protein kinase kinase 2	0	1	0	1
Dual specificity mitogen-activated protein kinase kinase 4	0	1	0	1
Orexin receptor type 1	0	0	0	1
Cathepsin B	0	1	0	1
N-arachidonyl glycine receptor	0	1	0	1
G-protein coupled bile acid receptor 1	0	1	0	1
Neuromedin-K receptor	0	0	1	1
Substance-K receptor	0	1	1	2
Neuromedin-K receptor	0	1	1	2
Substance-K receptor	0	1	0	1
Substance-K receptor	0	1	0	1
Growth hormone secretagogue receptor type 1	0	0	1	1
Protein argonaute-2	0	0	1	1
D(2) dopamine receptor	0	1	0	1
Chain A, Pyridoxal kinase	0	1	0	1
Chain A, Pyridoxal Kinase	0	1	0	1
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4D	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4C	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4B	0	1	0	1
Thyroid hormone receptor beta	0	1	0	1
Adenosine receptor A1	0	2	0	2
Adenosine receptor A1	0	1	0	1
cAMP-specific 3',5'-cyclic phosphodiesterase 4A	0	1	0	1
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B	0	1	0	1
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A	0	1	0	1
Chain A, ykoF	0	0	1	1
Chain B, ykoF	0	0	1	1
Chain A, ThiT	0	0	1	1
Thiamine transporter ThiT	0	0	1	1
Transketolase	0	0	1	1
Thiamine-binding periplasmic protein	0	0	1	1
Taste receptor type 2 member 38	0	0	0	1
Cathepsin D	0	1	0	1
Genome polyprotein	0	1	1	2
Krueppel-like factor 10	0	1	0	1
Chain A, Carbonic anhydrase 1	0	1	0	1
Carbonic anhydrase 2	0	1	0	1
Chain A, Nuclear Receptor ROR-beta	0	1	0	1
Ornithine decarboxylase	0	0	0	1
Retinoic acid receptor alpha	0	2	2	7
Retinoic acid receptor beta	0	2	2	7
Retinoic acid receptor alpha	0	1	2	3
Retinoic acid receptor gamma	0	2	2	7
Retinoic acid receptor gamma	0	1	2	3
Retinoic acid receptor beta	0	1	2	3
Cellular retinoic acid-binding protein 2	0	0	1	1
Mitogen-activated protein kinase 1	0	1	1	2
Retinoic acid receptor RXR-alpha	0	1	2	3
Retinoic acid receptor RXR-beta	0	2	2	4
Retinoic acid receptor RXR-beta	0	1	2	3
Retinoic acid receptor RXR-gamma	0	1	2	3
Nuclear receptor ROR-alpha	0	1	0	1
Cellular retinoic acid-binding protein 1	0	1	0	2
Retinoic acid receptor RXR-gamma	0	2	2	4
Cellular retinoic acid-binding protein 1	0	0	1	1
Nuclear receptor ROR-beta	0	1	0	1
Genome polyprotein	0	1	0	1
Lysozyme C-1	0	1	0	1
Protein kinase C alpha type	0	1	0	1
Beta-glucuronidase	0	1	0	1
Protein kinase C delta type	0	1	0	1
Protein kinase C epsilon type	0	1	0	1
Protein kinase C zeta type	0	1	0	1
Protein kinase C gamma type	0	1	0	1
Protein kinase C beta type	0	1	0	1
Protein kinase C eta type	0	1	0	1
Calcium-dependent protein kinase 4	0	1	0	1
Emopamil-binding protein-like	0	1	0	1
Protein kinase C theta type	0	1	0	1
Carnitine O-palmitoyltransferase 2, mitochondrial	0	1	0	1
Carnitine O-palmitoyltransferase 1, liver isoform	0	1	0	1
Carnitine O-palmitoyltransferase 1, muscle isoform	0	1	0	1
Mitogen-activated protein kinase 13	0	0	1	1
Mitogen-activated protein kinase 12	0	0	1	1
Mitogen-activated protein kinase 11	0	0	1	1
Chain A, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain K, Trp Rna-binding Attenuation Protein	0	0	1	1
Chain B, tryptophanyl-tRNA synthetase	0	0	1	1
Chain C, Tryptophanyl-tRNA synthetase II	0	0	1	1
Tryptophan 2,3-dioxygenase	0	1	0	2
Tryprostatin B synthase	0	0	0	1
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase	0	0	1	1
Chain A, CHORISMATE MUTASE	0	1	0	1
Chain A, TYROSYL-tRNA SYNTHETASE	0	0	1	1
Tubulin--tyrosine ligase	0	1	0	1
Taste receptor type 2 member 14	0	0	0	1
Urease subunit alpha	0	1	0	1
Urease subunit beta	0	1	0	1
Solute carrier family 2, facilitated glucose transporter member 9	0	1	1	2
Chain A, Arginase 1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member A1	0	1	0	1
Aldo-keto reductase family 1 member B7	0	1	0	1
NAD-dependent protein deacylase sirtuin-5, mitochondrial	0	1	0	1
Proprotein convertase subtilisin/kexin type 7	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1-like protein 1	0	1	0	1
Vitamin K epoxide reductase complex subunit 1	0	2	0	2
Chain E, cAMP-dependent protein kinase, alpha-catalytic subunit	0	1	0	1
Chain I, cAMP-dependent protein kinase inhibitor, alpha form	0	1	0	1
Chain B, Rho-associated protein kinase 1	0	1	0	1
Chain A, Rho-associated protein kinase 1	0	1	0	1
Chain A, Rho-associated protein kinase 1	0	1	0	1
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	0	1	0	1
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	0	1	0	1
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	0	1	0	1
Chain I, cAMP-dependent protein kinase inhibitor alpha	0	1	0	1
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	0	1	0	1
Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit	0	1	0	1
Chain I, cAMP-dependent protein kinase inhibitor alpha	0	1	0	1
Chain A, Rho-associated protein kinase 1	0	1	0	1
Rho-associated protein kinase 2	0	2	0	2
Ribosomal protein S6 kinase alpha-5	0	1	0	1
cAMP-dependent protein kinase catalytic subunit alpha	0	1	0	1
cAMP-dependent protein kinase catalytic subunit alpha	0	1	0	1
C-C motif chemokine 2	0	1	0	1
cAMP-dependent protein kinase catalytic subunit alpha	0	1	0	1
cAMP-dependent protein kinase catalytic subunit gamma	0	1	0	1
cAMP-dependent protein kinase catalytic subunit beta	0	1	0	1
Rho-associated protein kinase 1	0	2	0	2
Serine/threonine-protein kinase N2	0	1	0	1
Rho-associated protein kinase 2	0	1	0	1
Alpha-2A adrenergic receptor	0	1	0	1
Chain A, Human Adenosine A2A receptor/T4 lysozyme chimera	0	0	1	1
Chain A, Adenosine receptor A2a	0	0	1	1
Chain A, Adenosine receptor A2a	0	0	1	1
Hexokinase-4	0	1	0	1
Amine oxidase [flavin-containing]	0	1	0	1
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Synonyms(13)

Research Excerpts

Overview

Context

Actions

Treatment

Research

Studies (947)

Protein Targets (1,978)

Abnormal Movements

Synonyms(13)

Research Excerpts

Overview

Context

Actions

Treatment

Research

Studies (947)

Drugs Studied (429)

Protein Targets (1,978)